Medicines and poisons

Medicines and poisons

Medicines and Poisons is responsible for the monitoring and control of supply of scheduled substances in the Northern Territory (NT).

The following areas come under Medicines and Poisons and can be found on these pages or on the NT Government website:

Legislation

Medicines and poisons enforces compliance of these Acts:

Role

The Medicines and Poisons program has these key responsibilities:

  • issuing licences, registrations and authorisations under the relevant Acts
  • inspecting premises for compliance storage, record keeping, packaging, labelling, advertising and supply
  • scheduling of poisons and medicines
  • monitoring the movement of S8 medicines
  • issuing authorisations for the NT Opiate Pharmacotherapy Program
  • secretariat support for the Department of Health statutory committees:  

Contact

Medicines and Poisons
8th floor Manunda Place
38 Cavenagh Street
Darwin NT 0800

Phone: 08 8922 7341
Fax: 08 8922 7200
poisonscontrol@nt.gov.au

Mail

PO Box 40596
Casuarina NT 0811


Medicines and poisons notices

This page contains notices relating to the Medicines, Poisons and Therapeutic Goods Act 2012.

For COVID-19 vaccination administration protocols, go to the COVID-19 vaccine protocols page.

The notices allow certain health practitioners to possess, administer and supply scheduled substances under protocol.

Organisations outside NT Health need to use one of these application forms to apply for a new approval or request an update to an existing approval. The completed form and all attachments must be emailed to poisonscontrol@nt.gov.au

Document Sponsoring area Health practitionerDate
Resqmed Paramedic Medicines and Poisons, NT Health Paramedics 18 March 2024
Menzies Vaccination Medicines and Poisons, NT Health Nurses, Midwives, Aboriginal Health Practitioners 11 March 2024
DPH Staff Vaccination Medicines and Poisons, NT Health Nurses, Midwives 6 March 2024
NT Health Paramedic Chief Executive, NT Health Paramedics 14 December 2023
Pharmacist Vaccination Medicines and Poisons, NT Health Pharmacists 8 December 2023
PPHC Remote SSTP NT Health Remote Primary and Population Health Care clinics and health centres Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 9 October 2023
Aspen Medical - Barkly minesites Aspen Medical Nurses and paramedics 21 June 2023
Teck Australia SSTP - Barkly Tenements Teck Australia Paramedic 2 May 2023
Vitality Works SSTP Vitality Works Nurses and midwives 19 May 2023
Aspenmedical SSTP Aspenmedical - Wickham Point Nurses and paramedics 18 May 2023
ACCHO - SSTP Non-government community health centres and clinics Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 8 May 2023
Parabellum SSTP Parabellum International Paramedic 3 May 2023
SARC SSTP Chief Health Officer Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 14 March 2023
MPox SSTP Chief Health Officer Aboriginal and Torres Strait Islander health practitioners, midwives, nurses and pharmacists 14 March 2023
JE SSTP Chief Health Officer Aboriginal and Torres Strait Islander health practitioners, midwives, nurses and pharmacists 14 March 2023
MPTGA S254 Darwin Private Hospital Staff vaccinations 2 March 2023
G16 2022 BizHealth Consultants Pty Ltd Nurses 20 April 2022
S15 2022 HCA Corporate Health Pty Ltd Nurses 14 April 2022
G6 2022 p3-4 Immunisation - qualifications Pharmacists 9 February 2022
G51 2021 p7-8 Darwin Day Surgery and Golden Glow Corporation Nurses 16 December 2021
G46 2021 p2-10 Immunisation - prescribed qualifications to supply, administer or possess vaccines Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 17 November 2021
G44 2021 p7-17 Centre for Disease Control – Meningococcal B Vaccine Study “B Part of it NT” Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 3 November 2021
G34 2021 p8-11 Oral Health Services Dental Therapist, Dental Hygienist or Oral Health Therapist 25 August 2021
G29 2021 p2-4 Royal Flying Doctor Service Nurses and Midwives 21 July 2021
G23 2021 p6-9 Darwin Occupational Services (DOS) Nurses 9 June 2021
S12 2021 Medimobile Nurses 6 May 2021
G18 2021 - p1-4 Urban Schools Nurses and Midwives 5 May 2021
G13 2021 p4-7 Public Hospital Maternity Midwives 31 March 2021
G11 2021 p1-4 Urban Community Health Clinics Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 17 March 2021
S2 2021 Chief Health Officer Covid-19 response – declared site Darwin   15 January 2021
G39 2020 p4 Chief Health Officer Covid-19 response – declared sites Alice Springs and Tennant Creek   30 September 2020
G26 2020 p10-11 RDH ENT outpatient - declarations and approval Nurse and Midwives 1 July 2020
G20 2020 p4-7 Renal Services Aboriginal and Torres Strait Islander health practitioners and nurses 20 May 2020
G16 2020 Howard Springs facility declared place   22 April 2020
G13 2020 SMG Health Nurses 1 April 2020
S22 2019 CareFlight Nurses, Midwives and Paramedics 12 April 2019
S108 2018 AusHealth Corporate Pty Ltd Nurse and Midwives 19 December 2018
S81 2018 Northern Territory Alcohol and Drug Services Nurse and Midwives 5 October 2018
S55 2018 Correctional facilities centres and clinics Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 18 July 2018
S81 2017 Centre for Disease Control (CDC) - Immunisation Aboriginal and Torres Strait Islander health practitioners, midwives and nurses 10 Nov 2017
S94 2016 Sonic Healthplus Darwin Nurses 17 Aug 2016
S28 2016 NT Renal Services Nurses and Midwives 14 April 2016
S22 2016 VaxWorks Health Services Pty Ltd Nurses and Midwives 7 April 2016

S43 2015

Alice Springs Hospital Emergency Department Nurses and Midwives 6 May 2015
S36 2015 p4-5 Infection Prevention and Management Units Nurses and Midwives 23 Apr 2015
S35 2015 p9-10 Immunisation - Approval of SSTP for NCCTRC Pharmacists 21 Apr 2015

S24 2015

Primary Health Care, DoH - Police Stations and Watchhouses Nurses and Midwives 17 Mar 2015

G25 2014

Centre for Disease Control (CDC) - Extra vaccines and medicines Aboriginal and Torres Strait Islander health practitioners 25 Jun 2014
G25 2014 Centre for Disease Control (CDC) - Extra vaccines and medicines Nurses and Midwives 25 Jun 2014

S31 2014

Home Birth Services Midwives 30 Mav 2014

S24 2014

Family Planning Welfare NT (FPWNT)

Nurses and Midwives

1 May 2014

The following Government Gazettes mark the commencement of Medicines, Poisons and Therapeutic Goods Act 2012, in 2014.

TitleContentDate

G17 2014

Assent to Proposed Laws Medicines, Poisons and Therapeutic Goods Amendment Act (No 12 of 2014) 30 Apr 2014

G16 2014

Declared Medical Conditions 23 Apr 2014

G16 2014

Approval for Pharmacist to Supply S8 Substances on Interstate Prescription (Cross-Border Communities) 23 Apr 2014
G15 2014 Notification of Subordinate Legislation - Medicines, Poisons and Therapeutic Goods Regulations 16 Apr 2014

S8 Code of Practice and related documents

TitleContentDate
Section 243E Exemption from requirement to give information 17 December 2021
S42 2021 Exemption - S8 authorisation - During Emergency response - Medical practitioners and nurse practitioners Psychostimulants 7 December 2021
G10 2020 p2

Notice of making S8 Code of Practice – new edition of Part 4 Opioid Substitution Treatment

11 March 2020
G10 2020 p3 Declaration of Restricted S8 Substances 11 March 2020
G26 2020 p12-14

Exemption - S8 Authorisation for hospital patients

1 July 2020
G26 2020 p15-16

Exemption - S8 Authorisation - Authorised Health Practitioners at AODS and Corrections

1 July 2020
G26 2020 p17-18

Exemption - S8 Authorisation - Methadone liquid for patients in intensive care

1 July 2020
G26 2020 p19-20 Exemption - S8 Authorisation - Methadone liquid for palliative care patients 1 July 2020
G26 2020 p21-23 Exemption - S8 Authorisation - Patient transfers to and from AODS and corrections 1 July 2020
G26 2020 p24-27 Exemption - S8 Authorisation - Shared care providers - Patient transfers to and from AODS and corrections 1 July 2020
G17 of 2014 (4/17) p3 Exemption – S8 Authorisation – Prescribe psychostimulant in absence of authorised specialised prescriber in group practice/as locum 30 April 2014

Medical practitioners and schedule 8 medicines

This page has information for medical practitioners about the prescription and supply of Schedule 8 (S8) substances.

The Medicines, Poisons and Therapeutic Goods Act 2012 states that the following applies to medical practitioners:

  • authorised prescribers, including doctors, nurse practitioners, eligible midwives, dentists and veterinarians, are prohibited from prescribing a S8 substance to themselves
  • prescribers must check the Monitored Medicines database (NTScript) prior to issuing a prescription for a monitored medicine
  • the Chief Health Officer (CHO) can also declare Schedule 4 substances to be restricted if additional controls are needed to ensure safe access and use.

For information about the use prescribing contracts list please contact Medicines and Poisons during office hours on (08) 89227 341 or by emailing poisonscontrol@nt.gov.au

Read about the laws that apply to S8 drugs in the S8 Code of Practice, further down this page.

Restricted S8 substances

S8 substances are classified as either restricted or unrestricted.

Restricted S8 substances include:

  • buprenorphine depot Injections (Buvidal® and Sublocade®)
  • buprenorphine (Subutex®) 0.4mg, 2mg and 8mg for sublingual administration
  • buprenorphine/naloxone (Suboxone®) 2mg/0.5mg, 8mg/2mg in film form for sublingual or buccal administration
  • methadone liquid 5mg/mL for oral administration
  • dexamfetamine
  • lisdexamfetamine
  • methylphenidate.

Supply

The following applies for the supply of dexamphetamine, lisdexamfetamine and methylphenidate:

  • authorisation from the CHO is required for each individual patient before a prescription can be issued
  • only paediatricians, psychiatrists, physicians, neurologists and registrars in training in these disciplines may make the decision to initiate supply
  • other medical practitioners may continue supply after one of the above specialists or registrars has done so
  • under such a co-management situation the patient must be seen by a specialist or registrar at least every two years
  • specialists may initiate supply without an authorisation, but must obtain an authorisation if supply exceeds 30 days.

The following applies for the supply of buprenorphine (Subutex®), buprenorphine/naloxone (Suboxone®), buprenorphine depot Injections (Buvidal® and Sublocade®) and methadone liquid:

  • medical practitioners providing pharmacotherapies for opioid dependence need to complete approved training initially and demonstrate continued clinical involvement and the undertaking of refresher training
  • an authority from the CHO to supply buprenorphine, buprenorphine/naloxone, buprenorphine depot injections and methadone is required for each individual patient before a prescription can be written or supplied
  • the framework for supply of these medications covers the writing of prescriptions, details of authorisation requirements, period of supply, dispensing of medications and takeaway privileges.

Unrestricted S8 substances

Unrestricted S8 substances includes common analgesics such as morphine, oxycodone and tapentadol as well as some benzodiazepines such as alprazolam.

Supply

The following applies for the supply of unrestricted substances:

  • medical practitioners may supply unrestricted S8 substances for the treatment of medical and surgical conditions but not for the treatment of addiction
  • a medical practitioner may only supply unrestricted S8 substances for up to 15 patients at a time
  • this number does not include patients receiving palliative care in end of life situation, hospital inpatients or those in need of emergency treatment
  • a medical practitioner may apply to the CHO for an authority to prescribe unrestricted S8 substances for more than this number of patients
  • medical practitioners must notify the CHO of the supply of unrestricted S8 substances under certain circumstances, for example if supply exceeds 8 weeks, if certain dosage levels are exceeded or if their circumstances may be conducive to possible abuse.

Electronic Prescribing

The NT permits electronic prescriptions for all Schedule 4 and Schedule 8 medicines in accordance with the Electronic Transactions (Northern Territory) Act 2000.

This includes for interstate prescriptions and prescriptions for Medicinal Cannabis products, however there are separate regulations that apply to interstate prescriptions.

24-hour clinical advice

The Drug and Alcohol Clinical Advisory Service (DACAS) offers professional advice to medical practitioners, pharmacists and other health professionals 24-hours.

Call DACAS on 1800 111 092.

Storage and transport

Health professionals producing or storing controlled Schedule 8 drugs read the Code of Practice for Schedule 8 Substances: Storage and Transport.

Schedule 8 code of practice

Document title

Index

Document Description

Code of Practice S8s - Volume 1

Code of Practice S8 Substances

 

Code of Practice S8s - Volume 1 - Part 4

Code of Practice S8 Substances

 

Code of Practice S8s - Volume 1 - Part 4B

Code of Practice S8 Substances

 
Code of Practice S8s - Volume 2

Code of Practice S8 Substances

 

Appendix A - Notification of Supply of an Unrestricted S8 Substance

Appendix A

Notification Form

Appendix B - Application for Authority to Prescribe a Restricted S8 Psychostimulant Medication

Appendix B

Application Form

Appendix C - Application for Authority to Prescribe a Restricted S8 Substance for Addiction

Appendix C

Application Form

Appendix D - Clinical Assessment for the Level of Supervised Dosing

Appendix D

Assessment Tool

Appendix E1 - Application for Variation to Regular OSD Takeaway USD - Buprenorphine, Naloxone

Appendix E1

Application Form

Appendix E2 - Application for Variation to Regular OSD Takeaway USD - Methadone, Buprenorphine 

Appendix E2

Application Form

Appendix F - Applications for OSD Takeaway USD for Travel

Appendix F

Publications

Forms
Agreement for patients prescribed general medications
Opiate Pharmacotherapy Contract
Drug Loss, Incident or Discrepancy Report Form PDF (159.1 KB)
Drug Loss, Incident or Discrepancy Report Form DOCX (60.8 KB)
Information sheets
Requirements of Prescriptions for S8 Substances
Information for Patients on S8 Medications DOCX (65.9 KB) 
Interstate S8 prescriptions state phone and fax:
ACT
Phone: (02) 6205 0998
Fax: (02) 6205 0997
NSW
Main switch phone: (02) 9391 9944
Fax: (02) 9424 5860
Non-methadone phone: (02) 9424 5923
Fax: (02) 9424 5889
Methadone phone: (02) 9424 5921
Fax:(02) 9424 5885
Queensland
Phone: (07) 3328 9890
Fax: (07) 3328 9821
South Australia
Phone: 1300 652 584
Fax: 1300 658 447
Tasmania
Phone: (03) 6166 0400
Fax: (03) 6233 3904
Victoria
Phone: 1300 364 545 select #1
Fax: 1300 360 830
Western Australia 
Phone: (08) 9222 6883
Fax: (08) 9222 2463
NT
Phone: (08) 8922 7341
Fax: (08) 8922 7200
Medical Practitioner Guide to Supplying Isotretinoin (47KB)
The Scheduled Substances Clinical Advisory Committee (48KB)
Patient Delivered Partner Therapy (47KB)
Interstate Health Departments - S8 Drug Monitoring (44KB)
Recommended reading on treatment of pain
Opioid recommendations in general practice on the NSW Health website.
National Prescribing Service (NPS) Medicine Wise website
Patient guide to managing pain and opioid medicines Choosing Wisely Australia website

Related information

Read more about scheduled substances in the Clinical Advisory Committee (CLAC).

For information on the following topics go to medicines and poisons safety:

  • therapeutic goods recalls
  • buying medicines online.

NTScript information for health professionals

Planned Upgrade

As part of ongoing performance and security upgrades, the NT Script login experience will change over the end of 2023.

The login page for NT Script is being upgraded to make it faster and more secure to login. This will change the ‘backend’ location of the page.

For most users, there will be no change. For users who have not logged in for over a month, their log in page will not load and they will be redirected to another page.

If you have saved the Practitioner Login page to your bookmarks, go to the NT Script website. You will need to update your bookmark.

If you try to access the log in page, you will receive a notification redirecting you to the updated page.

If you access NTScript through www.ntscript.nt.gov.au, you will not be affected.

You can contact the Medicines and Poisons team on 0889 227341 or ntscript@nt.gov.au.

Background

Prescription medicines are an important tool to manage the health of Territorians, however there is growing evidence nationally that particular medicines carry a high risk of dependence, misuse and over-use that is leading to increasing numbers of avoidable hospitalisations and death.

In 2018 State and Territory Health Ministers in conjunction with the Commonwealth Department of Health agreed to participate in a federated Real Time Prescription Monitoring solution based on the Victorian SafeScript model. Under this model all the states and territories will integrate with a national data exchange to enable real time prescription monitoring across the jurisdictions.

Prescription monitoring in the NT

The NT Chief Health Officer has undertaken monitoring of Schedule 8 (S8) Controlled Drugs since 1983, with pharmacies providing a weekly report of dispensed S8 prescriptions. The data was only available directly to regulators working for the Chief Health Officer, with a process for providing patient S8 histories to validated medical practitioners on email or telephone request. The NT Coroner recommended in 2017 that the NT Government implement real time prescription monitoring of Schedule 8 drugs.

The aim of a Real Time Prescription Monitoring (RTPM) system is to reduce the risks of dose escalation, dependence and overdose of select medicines by increasing the sharing of information between prescribers, pharmacists and regulators. RTPMs support clinical decision-making and encourage conversations between health professionals and their patients to identify and reduce the risk of medication related harm.

In July 2020, an agreement was signed between NT Health, the Commonwealth Department of Health and software provider FredIT for the NT to link to the Commonwealth’s federated RTPM and to develop an RTPM system for the NT.

The system is known as NTScript.

What information is collected?

Prescription details collected by NTScript include:

  • name and address of the patient
  • name and address of prescriber
  • details of the practice where the prescriber is located
  • date prescription is issued by the prescriber
  • medicine details (name, brand, strength, quantity, instructions)
  • details of pharmacy which dispenses the medicine
  • date the medicine is dispensed

Which medicines are monitored?

“Monitored Substances” are those medicines that greatly increase risk to the patient due to likelihood of dose escalation, dependence, overdose, misuse and diversion.

NTScript replaces the monitoring system for Schedule 8 medicines in the NT that has been in operation since 2004.

S8 medicines include strong pain relievers such as morphine (e.g. MS Contin®, Kapanol®) and oxycodone (e.g. OxyContin®, Targin®), stimulants used to treat ADHD, narcolepsy and autosomal hypersomnolence (e.g. Ritalin®, Vyvanse®), and opioid substitution medicines methadone, buprenorphine and buprenorphine/naloxone.

Some Schedule 4 medicines have a recognised risk of overuse, overdose and death and as such have been recommended by experts to be included in RTPM systems. The additional monitored medicines includes:

  • All benzodiazepines not in S8 –  e.g. diazepam (Valium® , Antenex®)
  • “Z-drugs” – zolpidem (e.g. Stilnox®) and zopiclone (e.g. Imovane®)
  • quetiapine (e.g. Seroquel®)
  • gabapentin (e.g. Neurontin®)
  • Pregabalin (e..g Lyrica®)
  • codeine combination products e.g. Panadeine Forte®
  • tramadol

Supporting safe medicine use

NTScript does not determine if a medicine can or cannot be prescribed or supplied. If someone is receiving monitored medicines at high dose, high risk combinations or receiving monitored medicines from multiple providers they will be at a high risk of harm. Data in NTScript will be used to determine risk, coordinate care and support the safe and effective supply of medicines.

Identifying risks

The information in NTScript will help prescribers and pharmacists work with their patients to identify and manage risks. NTScript will generate Alerts within the software when criteria known to increase risk are present. Clinicians using conformant software will also see pop-up Notifications at the time of prescribing/dispensing to help identify where there is information in NTScript that should be considered.

Can someone opt out?

NTScript continues the mandatory monitoring in place since 1983 in the NT. It is not possible to opt out as the use and supply of these “monitored of substances” is a major public health and safety concern, to individual patients and to the general community.

How is privacy protected?

All data in NTScript is encrypted and stored in accordance with Commonwealth Department of Defence IT Standards. Access to NTScript is limited to prescribers, pharmacists and regulators. Users log in with multifactorial authentication which greatly reduces the risk of unauthorised access. All access to NTScript by any user is logged and privacy is protected under the NT Information Act 2002 and Commonwealth Privacy Act 1988.

How is patient consent managed?

The final decision to have a medicine prescribed or supplied is up to the patient in conjunction with their treating health professional.  Health professionals should inform their patient when a medicine will be included in NTScript so that patients can choose not to receive the monitored medicine and alternative treatment or referral should then be provided instead.

Who can access the information?

  • By law NT Script data can be accessed by certain classes of health practitioner registered with a national board.  The health practitioners are prescribers (doctors, dentists, nurse practitioners, endorsed midwives and podiatrists) and pharmacists. These health practitioners first need to register for NTScript.
  • An authorised user is allowed to access NTScript only to aid clinical decision making for providing direct care to a particular person.
  • NT Department of Health staff who are responsible for the regulation of medicines on behalf of the Chief Health Officer will also have access as part of their duties.
  • Patients can view information held against their details when they are discussing treatment options with their treating health practitioner, provided the health practitioner is registered for NTScript.
  • Patients can also submit a Freedom of Information (FOI) request to the NT Department of Health.

Registration access and training

Eligible prescribers and pharmacists can register and access NTScript from the NTScript portal.

Contact details

Medicines and Poisons
NT Department of Health
Email: NTScript@nt.gov.au
Phone: (08) 8922 7341


Pharmacists

This page has information for pharmacists about prescription requirements, schedule 8 (S8) medicines and the pharmacist immunisations.

Pharmacists must familiarise themselves with the Medicines, Poisons and Therapeutic Goods Act 2012 and Regulations and the Code of Practice S8 Substances.

NT Script has been operational in the Northern Territory (NT) for some time and there is a legal requirement for every pharmacist to check when presented with a prescription for a schedule 8 or monitored medicine. Read further information about NT Script.

To get the S8 Code of Conduct see medical practitioners and schedule 8 medicines.

Unrestricted S8 substances

Prescribers must notify Medicines and Poisons of the supply of unrestricted S8 substances such as morphine and oxycodone if supply exceeds 8 weeks, or if other circumstances arise that are in the Code of Practice.

Prescribers may require authorisation if they choose to prescribe for more than an approved number of patients.

Compliance is the responsibility of the prescriber, and pharmacists are not expected to routinely monitor these matters as a part of dispensing.

However pharmacists email poisonscontrol@nt.gov.au if they have particular queries or concerns.

Restricted S8 substances

These categories of S8 substances have the following supply restrictions applied to them.

Stimulants

Stimulants include dexamfetamine, lisdexamfetamine and methylphenidate.

General medical practitioners and nurse practitioners can co-prescribe in conjunction with a specialist paediatrician, psychiatrist, neurologist, physician or registrar in training in one of these disciplines.

Prescribers are required to obtain authorisation before prescribing these substances.

Pharmacists are not required to check whether a prescriber has obtained authorisation, however they may contact Medicines and Poisons with queries or concerns.

Opioid Substitution Treatment (OST)

Methadone, buprenorphine and buprenorphine/naloxone.

Eligible health practitioners who wish to prescribe OST must:

  • be accredited by the CHO and
  • must also apply and receive authorisation for each patient they wish to prescribe the restricted S8 OST substance for.

More information for prescribers about accreditation and training to become an OST prescriber, contact the local Alcohol and Other Drugs Service:

Top End Alcohol and other Drug Services 
Building 9, Royal Darwin Hospital
Phone: 08 8922 8399

Alcohol and other Drugs Services Central Australia (ADSCA)
The Gap NT 0870
Phone: 08 8951 7580

Medicines and Poisons can provide information on whether prescribers are accredited.

Prescription requirements

The S8 Code has these requirements for prescriptions of controlled drugs:

  • prescriptions for unrestricted S8 substances such as morphine are valid for 6 months, with dispensing of one month’s supply at any one time
  • prescriptions for restricted S8 psycho-stimulants (dexamphetamine, lisdexamfetamine and methylphenidate) are valid for 6 months
  • prescriptions for restricted S8 substances buprenorphine, buprenorphine/naloxone and methadone 5mg/mL are valid for 3 months - they must be dispensed within 3 days of the date of issue or the start date (if different)
  • according to the S8 Code the following items must be written on all S8 prescriptions, in addition to usual requirements for prescriptions:
    • the date of birth of the patient
    • the type of preparation i.e. liquid or sublingual tablets
    • doses in words and numbers for buprenorphine, buprenorphine/naloxone and methadone
    • quantities in words and numbers for unrestricted S8 substances and psycho-stimulant medication, unless issued by a conformant electronic prescribing system
  • a prescription must be written in ink, not in pencil or another easily erasable material
  • if there are any changes to the details, the initials of the person who issued the prescription and the date the change was made must appear beside each change
  • prescribers must sign prescriptions in their handwriting unless they are using an electronic prescribing system
  • prescribers of buprenorphine, buprenorphine/naloxone and methadone liquid, also need to include the name of the dispensing pharmacy as well as a detailed dosage regimen and any takeaway privileges.

Interstate prescriptions

Dispensing from prescriptions written by prescribers based interstate is permitted for schedule 4 medicines.

Prescriptions for unrestricted schedule 8 medicines written by interstate prescribers can be dispensed in the NT in line with Regulation 7A of the regulations which outlines that a pharmacist must verify:

  1. the validity of the prescription - the prescription must meet all legal requirements that apply to prescriptions written in the NT
  2. the identify of the person presenting the prescription.

Prescriptions for restricted schedule 8 medicines that are psychostimulants (methylphenidate, dexamphetamine, lisdexamphetamine) medicines written by interstate prescribers can be dispensed in the NT where the prescriber would normally be endorsed to initiate treatment in the Territory. This includes:

  • paediatricians
  • psychiatrists
  • neurologists
  • physicians.

The prescription will often include the prescriber’s qualifications. Otherwise prescriber qualifications can be checked on the AHPRA website.

National Poisons Standard

The latest version of the national Poisons Standard including the Standard for Uniform Scheduling of Medicines and Poisons (SUSMP) is available on the Therapeutic Goods Administration (TGA) website.

Publications

Forms
Drug Loss, Incident or Discrepancy Report Form PDF (159.1 KB)
Drug Loss, Incident or Discrepancy Report Form DOCX (60.8 KB)
LAIB injection log PDF (59.1 KB)
Information sheets
Requirements of prescriptions for S8 substances DOCX (61.9 KB)
Supplying without a prescription PDF (559.7 KB)
Continued dispensing initiative DOCX (60.6 KB)
Disposal of S8 substances PDF (565.7 KB)
Alcohol substitution products fact sheet for mouthwash and essence flavourings
Methylated spirits fact sheet
Guidance on dispensing for pharmacists PDF (578.0 KB)
Guidance for dealing with a fraudulent or suspicious prescription in the pharmacy DOCX (59.3 KB)
Pharmacist administration of LAIB PDF (191.2 KB)

Related information

Read more about scheduled substances on Clinical Advisory Committee (CLAC).

For information on the following topics, go to the Northern Territory Government website:

  • therapeutic goods recalls
  • buying medicines online.

Pharmacist vaccinations

For COVID-19 vaccination administration protocols, go to the COVID-19 Vaccine Protocols page.

Pharmacists have been vaccinating in the NT since 2015.

On 8 December 2023 the NT Chief Health Officer approved a new Scheduled Substance Treatment Protocol (SSTP) for pharmacist vaccination which applies to all pharmacists in the NT.

Pharmacists are now enabled to administer a broader range of vaccines in the NT without a prescription:

  • For people aged 5 years and over
  • For a defined range of vaccines
  • Where they have undergone immunisation specific training
  • Where the immunisation is in accordance with public health programs (National Immunisation Program, NT Immunisation Schedules)

The full range of vaccines and indications is listed on the SSTP PDF (849.6 KB).

At this time, the SSTP does not enable travel vaccines or occupational vaccination where this does not align with the NIP and NT Schedules.

Using the NIP and NT Schedules

The National Immunisation Program (NIP) Schedule is a series of immunisations given at specific times throughout a persons life.

The National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program is a commonwealth initiative enabled through NT health and is effective from 1 January 2024. The NIPVIP enables participating pharmacists to receive vaccines at no cost and increases access for eligible (under the NIP) people to access FREE NIP vaccines in a community pharmacy with no out of pockets costs.

This range of conditions and people are outlined on the National Immunisation Program Schedule

Pharmacists may vaccinate people in line with the NIP schedule, regardless if they are doing so under NIP program rules and funding models or if the patient is choosing to pay privately.

The NT Health Immunisation Schedules outline the priority vaccinations to meet the unique needs of the NT. This is based on the NIP schedule with minor amendments and increased eligibility for some Indigenous patients.

Pharmacists may vaccinate people in line with the NT Schedule or National Immunisation Program schedule however payment under the NIPVIP is based on the NP vaccines in a pharmacy setting for individuals aged 5 years and over.

Pharmacists vaccinating at pharmacy premises

Pharmacy premises must meet the Pharmacy Premises Standard PS5

Pharmacists vaccinating at other locations

The SSTP outlines the minimum requirements of a location where pharmacists will be administering medicines. This includes critical concepts such as anaphylaxis management, cleanliness, waste disposal and cold chain management.

Intern Pharmacists

Pharmacists with provisional registration (intern pharmacists) are able to administer vaccines provided they adhere to the requirements as outlined in the SSTP and are under the supervision of a pharmacist who is qualified to vaccinate.

Further Information

If you are a pharmacy owner, manager of a pharmacy or pharmacist and you are interested in providing an immunisation service please contact:

The Registrar, Pharmacy Premises Committee
PPCRegistrar.DoH@nt.gov.au

Or

Medicines and Poisons
Poisonscontrol@nt.gov.au


Therapeutic medicines containing cannabinoids (medicinal cannabis)

The Australian Government Department of Health regulates therapeutic medicines containing cannabis through the Therapeutic Goods Administration and for importation or production, the Office of Drug Control.

Access is restricted to patients where there is evidence to support its therapeutic use.

For further information read the:

Patients living in the Northern Territory

Medical cannabis pharmaceuticals are prescription medicines, so access for each patient starts with assessment by a medical practitioner. General practitioners (GPs) may refer a patient to a specialist to obtain further advice and support before deciding to prescribe a medicinal cannabis pharmaceutical.

The Northern Territory does not apply any specific regulation to the prescribing and supply of medicinal cannabis pharmaceuticals.

However a doctor must obtain approval from the Therapeutic Goods Administration under the Special Access or Authorised Prescriber Schemes (or for a Clinical Trial) before issuing a prescription or supplying a medicinal cannabis pharmaceutical which is not on the Australian Register of Therapeutic Goods (ARTG).

Some medicinal cannabis pharmaceuticals are classified as Schedule 8 medicines depending on their THC content. Schedule 8 medicines have extra requirements in the NT including reporting to the monitored medicines database, prescription contents and supply and storage requirements.

For further information read the:


Northern Territory hospital formulary

The NT Hospital formulary is a list of core medicines which are approved for use within NT public hospitals and health services. Through a Territory-wide approach to the availability of medicines, NT Department of Health (DoH) aims to optimise the quality use of medicines, improve and promote equity of access to medicines and increase the cost-effectiveness of medicine use across the NT.

Download the NT Hospital formulary DOCX (434.0 KB)

For any queries related to NT Hospital Formulary, email NTDTC.DoH@nt.gov.au.

Search medicines from the list

Formulary listing key:

  • Y – Listed on NT Hospital Formulary and not restricted
  • S – Highly Specialised Drugs Program (Section 100)
  • R – Listed on NT Hospital Formulary with restrictions

Drug

Dose form

Strength

Formulary Listing

Notes

ABACAVIR

Tablet

300mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ABACAVIR & LAMIVUDINE

Tablet

600/300mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ABIRATERONE

Tablet

250mg

R

Restricted to Haematology and Oncology for PBS listed indications.

ACAMPROSATE

Tablet

333mg

R

Restricted to Addiction medicine prescribers

ACETAZOLAMIDE

Injection

500mg

Y

 

ACETAZOLAMIDE

Tablet

250mg

Y

 

ACETIC ACID

Solution

0.25% & 5%

Y

 

ACETONE

Liquid

 

Y

 

ACETYLCHOLINE

Intraocular Irrigation

1% (2mg/2mL)

Y

 

ACETYLCYSTEINE

Injection

2g/10mL

Y

 

ACETYLCYSTEINE

Nebulised vial

800mg/4mL

Y

 

ACICLOVIR

Injection

250mg

Y

 

ACICLOVIR

Tablet

200mg & 800mg

Y

 

ACICLOVIR

Ointment

3%

Y

 

ACICLOVIR COLD SORE

Cream

5%

Y

 

ACTIVATED CHARCOAL

Oral Liquid

0.2g/mL

Y

 

ADALIMUMAB

Injection

40mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ADEFOVIR DIPIVOXIL

Tablet

10mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ADENOSINE

Injection

6mg/2mL

Y

 

ADRENALINE (EPINEPHRINE)

Injection

1 in 1000 & 1 in 10 000

Y

 

ADRENALINE (EPINEPHRINE)

Min-I-Jet

1 in 1000

Y

 

ADRENALINE (EPINEPHRINE)

Auto-injector

300 mcg & 150 mcg

R

EPI-PEN® AND EPI-PEN® JUNIOR

Restricted to after-hours use only by the Emergency Department.

ALBENDAZOLE

Tablet

200mg

Y

 

ALCOHOL

Injection

100%

Y

 

ALCOHOL

Solution

70% untinted, 95% untinted, absolute

Y

 

ALCOHOL STERILE SPRAY

Spray

70%

Y

 

ALENDRONATE

Tablet

70mg

Y

 

ALFENTANIL

Injection

1mg/2mL

Y

 

ALLOPURINOL

Tablet

100mg & 300mg

Y

 

ALPROSTADIL

Injection

500 mcg

Y

 

ALTEPLASE

Syringe

Vial

2mg/2mL

Y

Cathflo® to be restricted for supply to services where logistics of delivering and storing the frozen pre-filled syringe is not available.

Note: There is a current global shortage issue with alteplase. There is a requirement to conserve alteplase stock for life-saving indications only.

ALTEPLASE

Injection

10mg

R

Restricted for use by respiratory specialists/advanced trainees with experience in its use for empyema management

Note: There is a current global shortage issue with alteplase. There is a requirement to conserve alteplase stock for life-saving indications only.

ALTEPLASE

Injection

50mg

R

Restricted to Cardiology and ICU only

Restricted to ED for stroke thrombolysis under direction of the Neurologist.

Note: There is a current global shortage issue with alteplase. There is a requirement to conserve alteplase stock for life-saving indications only.

AMIES MEDIUM SWABS

Single Swabs

 

Y

 

AMIKACIN

Injection

500mg/2mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

AMINO ACID AND CARBOHYDRATE SUPPLEMENT (HEPATICAL®)

Sachet

100grams

Y

 

AMINO ACID LONG CHAIN POLYUNSATURATED FATTY ACIDS

Powder

 

R

Restricted to PBS indications.

AMINO ACIDS 7% GLUCOSE

Solution

7%

Y

 

AMINOPHYLLINE

Injection

250mg

Y

 

AMIODARONE

Injection

150mg

Y

 

AMIODARONE

Tablet

100mg & 200mg

Y

 

AMISULPRIDE

Tablet

100mg, 200mg & 400mg

R

Restricted to Mental Health

AMITRIPTYLINE

Tablet

10mg, 25mg & 50mg

Y

 

AMLODIPINE

Tablet

5mg & 10mg

Y

 

AMOXICILLIN

Suspension

250mg/5mL

Y

 

AMOXICILLIN

Capsule/ Tablet

250mg, 500mg & 1000mg

Y

 

AMOXICILLIN, CLARITHROMYCIN & ESOMEPRAZOLE (Nexium HP7 Triple Therapy Pack®)

Tablet

500mg/ 250mg/ 20mg

Y

 

AMOXICILLIN/ CLAVULANIC ACID

Injection

1g+200mg, 500mg+100mg, 2g+200mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

AMOXICILLIN/ CLAVULANIC ACID (Augmentin Duo®)

Tablet

500/125mg & 875/125mg

Y

 

AMOXICILLIN/ CLAVULANIC ACID (Augmentin Duo®)

Suspension

400/57mg /5mL

Y

 

AMPHOTERICIN

Lozenges

10mg

Y

 

AMPHOTERICIN LIPOSOMAL

Injection

50mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

AMPICILLIN

Injection

500mg & 1g

Y

 

ANAKINRA

Injection

100mg

R

Restricted to ICU Physicians as per use in REMAP CAP clinical trials only

ANASTROZOLE

Tablet

1mg

R

Restricted to Oncology and Haematology only

ANIDULAFUNGIN

Injection

100mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

ANTIVENOM BOX JELLYFISH

Injection

20 000 units

Y

 

ANTIVENOM-BLACK SNAKE

Injection

18 000 units

Y

 

ANTIVENOM-BROWN SNAKE

Injection

1 000 units

Y

 

ANTIVENOM-DEATH ADDER

Injection

6 000 units

Y

 

ANTIVENOM-POLYVALENT SNAKE

Injection

40 000 units

Y

 

ANTIVENOM-RED BACK SPIDER

Injection

500 units

Y

 

ANTIVENOM-SEA SNAKE

Injection

1000 units

Y

 

ANTIVENOM-STONE FISH

Injection

2000 units

Y

 

ANTIVENOM-TAIPAN SNAKE

Injection

12 000 units

Y

 

APIXABAN

Tablet

2.5mg & 5mg

R

Restricted to PBS indications.

APRACLONIDINE

Eye drop

0.50% (5mg/mL)

Y

 

AQUEOUS CREAM

Cream

 

Y

 

ARGIPRESSIN (VASOPRESSIN)

Injection

20units

R

Restricted to ICU

ARIPIPRAZOLE

Tablet

10mg, 15mg, 20mg & 30mg

R

Restricted to Mental Health for the treatment of schizophrenia.

ARIPIPRAZOLE (Abilify Maintena®)

Depot Injection

300mg & 400mg

R

Restricted to Mental Health for the treatment of schizophrenia.

ARTEMETHER & LUMEFANTRINE (Riamet®)

Tablet

20mg/120mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

ARTESUNATE

Injection

60mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

ASCORBIC ACID

Injection

15g/100mL

R

REMAP CAP Trial as prescribed by the ICU consultants.

ASCORBIC ACID

Tablet

500mg

Y

 

ASPIRIN

Dispersible tablets

300mg

Y

 

ASPIRIN

Tablet

100mg

Y

 

ATAZANAVIR

Capsule

200mg & 300mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ATAZANAVIR & COBICISTAT

Tablet

300mg+150mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ATENOLOL

Tablet

50mg

Y

 

ATENOLOL

Liquid

50mg/10mL

Y

 

ATORVASTATIN

Tablet

10mg, 20mg, 40mg & 80mg

Y

 

ATOVAQUONE & PROGUANIL

Tablet

250mg/100mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

ATRACURIUM

Injection

25mg

Y

 

ATROPINE SULFATE

eye drop & Minims

1%

Y

 

ATROPINE SULFATE

Injection

600mcg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

AZACITIDINE

Injection

100mg

R

Restricted to Haematology and Oncology for PBS listed indications.

AZATHIOPRINE

Tablet

25mg & 50mg

Y

 

AZITHROMYCIN

Injection

500mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

AZITHROMYCIN

Suspension

200mg/ 5mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for bronchiectasis in paediatric patients.

AZITHROMYCIN

Tablet

500mg & 600mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for bronchiectasis in paediatric patients and for susceptible infections not listed on the PBS approved by Infectious Disease/Tuberculosis clinic only.

AZTREONAM

Injection

1g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

BACLOFEN

Intrathecal Injection

10mg/5mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

BACLOFEN

Tablet

10mg & 25mg

Y

 

BALANCED SALT

Solution

 

Y

 

BATH WASH (Q.V. SOAP FREE KIDS WASH®)

Wash

 

Y

 

MYCOBACTERIUM BOVIS (BACILLUS CALMETTE AND GUERIN (BCG) STRAIN BLADDER INSTALLATION (Immucyst®)

Syringe

 

R

Restricted to Urologist

BCG VACCINE

Injection

 

Y

 

BECLOMETHASONE

Nasal Spray

50mcg

Y

 

BECLOMETASONE/FORMOTEROL/

GLYCOPYRRONIUM (Trimbow®)

Inhaler

100mcg/6mcg/ 10mcg

R

Restricted to PBS indications.

BENDAMUSTINE

Injection

25mg & 100mg

R

Restricted to Haematology/Oncology.

BENZATHINE PENICILLIN (LA Bicillin®)

Injection

1,200,000 Units (900mg)/2.3mL,

600,000 Units (517mg)/1.17mL

Y

 

BENZOIN COMPOUND (Friars’ Balsam Tincture)

Tincture

 

Y

 

BENZTROPINE

Injection

2mg

Y

 

BENZTROPINE

Tablet

2mg

Y

 

BENZYDAMINE (Difflam®)

Liquid

22.5mg/15mL

Y

 

BENZYDAMINE/ LIDOCAINE (LIGNOCAINE)/DICHLOROBENZYL ALCOHOL (Difflam Plus ®)

Lozenges

3mg/4mg/1.2mg

Y

 

BENZYL BENZOATE

Solution

25%

Y

 

BENZYLPENICILLIN

Injection

600mg, 1.2g & 3g

Y

 

BENZYLPENICILLIN (PENICILLIN G)

Infusor

3.6g/6g

Y

 

BETAHISTINE

Tablet

16mg

Y

 

BETAMETHASONE (Celestone Chronodose®)

Injection

5.7mg/mL

Y

 

BETAMETHASONE DIPROPIONATE

Ointment/ Cream

0.05%

Y

 

BETAMETHASONE DIPROPIONATE/ CALCIPOTRIOL

Ointment

0.05%/0.005%

Y

 

BETAMETHASONE VALERATE

Cream

0.02%

Y

 

BETAXOLOL

Eye drops

0.25% & 0.5%

Y

 

BEVACIZUMAB

Intravitreal Injection

 

R

Restricted to eye clinic - for Ophthalmology specialist use only.

Avastin® brand only. Not to substitute with biosimilars.

For SAS Avastin®, please complete appropriate SAS form (Category B) which can be located on the TGA website. SAS form is not required for TGA-approved Authorised Prescribers.

BEVACIZUMAB

Injection

100mg/4mL, 400mg/16mL

R

Restricted to Haematology and Oncology for PBS listed indications.

BICALUTAMIDE

Tablet

50mg

R

Restricted to Haematology and Oncology

BICTEGRAVIR, EMTRICITABINE & TENOFOVIR ALAFENAMIDE

Tablet

50mg+200mg+25mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

BIFIDOBACTERIA BIFIDUM & LACTOBACILLUS ACIDOPHILIS (Infloran®)

Capsule

1 x 109

1 x 109

R

Restricted to Special Care Nursery and Neonatal Intensive Care Unit.

BIFIDOBACTERIUM INFANTIS, BIFIDOBACTERIUM BIFIDUM, LACTOBACILLUS ACIDOPHILUS (Labinic Paediatric Drops ®)

Drops

1.5 billion CFU/0.16mL

R

Restricted to Special Care Nursery and Neonatal Intensive Care Unit during the period that Infloran® is unavailable.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

BISACODYL

Tablet

5 mg

Y

 

BISACODYL

Enema

10mg/5mL

Y

 

BISACODYL

Suppository

10mg

Y

 

BISMUTH & IODOFORM GAUZE

GAUZE

 

Y

 

BISOPROLOL

Tablet

2.5mg, 5mg & 10mg

Y

 

BIVALIRUDIN

Injection

250mg

R

Restricted to use in RDH ICU by ICU specialists only – please refer to RDH ICU: Medical Management of suspected Heparin Induced Thrombocytopaenia with or without Thrombosis (HIT/HITTS) guideline

BLEOMYCIN

Injection

15,000 international units

R

Restricted to Haematology and Oncology for PBS listed indications.

BNT162b2 [mRNA] COVID-19 VACCINE (Comirnaty®)

Injection

 

R

As per eligibility criteria outlined in the Australian Government Immunisation Implementation plan January 2021

BONE CEMENT with TOBRAMYCIN

  

Y

 

BORTEZOMIB

Injection

1mg & 3.5mg

R

Restricted to Haematology and Oncology for PBS listed indications.

BOSENTAN

Tablet

62.5mg & 125mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Restricted to patients <18 years old. Macitentan is first line for adults.

BOTULINUM A TOXIN

Injection

100 units & 500 units

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Restricted to surgical division/gastroenterology for treatment of anal fissure repair for patients who have failed conservative/first-line medical measures (100 unit injection only).

Restricted to Maxillofacial surgeons for patients ≥12 years of age for the following indications (100 unit injection only):
* For muscle relaxation/myofascial pain in MRI-proven temporomandibular joint dysfunction; first bite syndrome

* For salivary leaks/collections following procedures on or through (access to mandibular condyle) the parotid gland/parotidectomy
* For fracture management (e.g. condylar fractures)
* For the management of ‘gustatory sweating’ (Frey Syndrome) after parotid surgery

BRANCHED CHAIN AMINO ACIDS POWDER

Sachet

 

Y

 

BREXPIPRAZOLE

Tablet

1mg, 2mg, 3mg & 4mg

Y

 

BRIMONIDINE

Eye drops

0.20%

Y

 

BRINZOLAMIDE

Eye drops

1%

Y

 

BROMHEXINE

Elixir

Tablet

4mg/5mL

8mg

Y

 

BROMOCRIPTINE

Tablet

2.5mg

Y

 

BUDESONIDE

Nasal Spray

64mcg

Y

 

BUDESONIDE

Capsule and Tablet

3mg & 9mg

R

Blanket approval for inpatient and outpatient supply. Restricted to gastroenterologists for the;

Induction therapy for extensive ulcerative colitis if no response to sulfasalazine or mesalazine, or intolerance to either drug – 8 weeks therapy

Treatment of microscopic colitis – ongoing

Contraindications to prednisolone for the treatment of autoimmune gastrointestinal diseases (e.g. refractory coeliac disease, eosinophilic esophagitis, autoimmune hepatitis, inflammatory bowel disease) – ongoing

BUDESONIDE

Turbuhaler

100mcg, 200mcg & 400mcg

Y

 

BUDESONIDE

Respule

500mcg/2mL & 1mg/2mL

Y

 

BUDESONIDE/ FORMOTEROL (EFORMETEROL) (Symbicort®)

Rapihaler

50/3mcg &

100/3mcg & 200/6mcg

Y

BUPIVACAINE

Infusion

0.125%, 0.25% & 0.5%

Y

BUPIVACAINE & ADRENALINE

Injection

0.25%/ 1:400,000

Y

BUPIVACAINE & FENTANYL

Injection

0.125%/2mcg/ mL

Y

BUPIVACAINE & FENTANYL

Injection

0.0625%/2.5mcg/mL

Y

*For use as labour epidural

BUPIVACAINE & GLUCOSE

Injection

0.5%

R

Operating Theatre

BUPRENORPHINE

Sublingual Tablet

400mcg, 2mg & 8mg

R

Restricted to Addiction medicine prescribers

BUPRENORPHINE

Sublingual Tablet

200mcg

R

Restricted to Acute Pain Specialists for patients who are:

Inpatients only

and

The patient is unable to absorb via the oral route

and

A discharge plan for analgesia has been considered

or

It’s a continuation of regular mediation

BUPRENORPHINE (Norspan®)

Patch

5mg (5 mcg/hr), 10mg (10 mcg/hr) & 20mg (20 mcg/hr)

R

Chronic severe disabling pain not responding to non-narcotic analgesics.

BUPRENORPHINE & NALOXONE

Sublingual Film

2mg/0.5mg & 8mg/2mg

R

Restricted to Addiction medicine prescribers

BUPRENORPHINE (Buvidal®)

Weekly Depot Injection

8 mg/0.16 mL,

16 mg/0.32 mL,

24 mg/0.48 mL &

32 mg/0.64 mL

R

Restricted to Addiction medicine prescribers

BUPRENORPHINE (Buvidal®)

Monthly Depot Injection

64 mg/0.18 mL,

96 mg/0.27 mL,

128 mg/0.36 mL &

160mg/0.45mL

R

Restricted to Addiction medicine prescribers

BUPRENORPHINE (Sublocade®)

Monthly Depot Injection

100mg/0.5mL &

300mg/1.5mL

R

Restricted to Addiction medicine prescribers

CABAZITAXEL

Injection

60mg

R

Restricted to Haematology and Oncology for PBS listed indications.

CABERGOLINE

Tablet

1mg

Y

CABOTEGRAVIR

Tablet

30mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

CABOTEGRAVIR & RILPIRIVINE (combination pack)

Injection

600mg/3mL & 900mg/3mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

CAFFEINE (BASE)

Oral Solution

10mg/mL (50mL)

Y

CAFFEINE (BASE)

Injection

20mg/2mL

Y

CALAMINE

Lotion

15%

Y

CALCITRIOL

Capsule

0.25mcg

Y

CALCIUM & MAGNESIUM CHLORIDE

Haemofiltration infusion

R

To ICU only

CALCIUM CARBONATE

Tablet

1.25g

Y

CALCIUM CARBONATE/COLECALCIFEROL (CHOLECALCIFEROL)

Tablet

1.5g/12.5mcg

R

Restricted to Haematology and Oncology.

CALCIUM CHLORIDE

Injection

10%

Y

CALCIUM DISODIUM EDETATE

Injection

500mg/10mL

R

Stock held by RDH Emergency Department for treatment of severe lead poisoning.

CALCIUM FOLINATE

Injection

50mg

Y

CALCIUM FOLINATE

Tablet

15mg

Y

CALCIUM GLUCONATE

Injection

931mg/10mL

(2.2 mmol/10mL elemental calcium); also formerly known as Calcium Gluconate

10%

Y

CALCIUM GLUCONATE

Gel

2.50%

Y

CANDESARTAN

Tablet

4mg & 16mg

Y

CAPECITABINE

Tablet

150mg & 500mg

R

Restricted to Haematology and Oncology for PBS listed indications AND for EOX protocol for upper GI.

CAPSAICIN

Cream

0.075%

Y

For acute treatment of cannabinoid hyperemesis syndrome.

CAPTOPRIL

Solution

25mg/5mL

Y

CARBAMAZEPINE

Modified release Tablets

200mg & 400mg

Y

CARBAMAZEPINE

Tablet

200mg

Y

CARBAMAZEPINE

Suspension

100mg/5mL

Y

CARBIMAZOLE

Tablet

5mg

Y

CARBETOCIN

Injection

100mcg/mL

R

Restricted to Obstetrician or Anaesthetist in attendance for prevention of uterine atony and postpartum haemorrhage following the delivery of an infant by elective caesarean section under epidural or spinal anaesthesia

CARBOPLATIN

Injection

150mg/5mL, 450mg/45mL & 50mg/5mL

R

Restricted to Haematology and Oncology for PBS listed indications.

CARBOPROST

Injection

250mcg/mL

Y

CARMELLOSE (Cellufresh®)

Eye drop

0.50%

Y

CARNITINE

Solution

1g/10mL

Y

CARVEDILOL

Tablet

3.125mg, 6.25mg, 12.5mg & 25mg

Y

CASPOFUNGIN

Injection

50mg & 70mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFALEXIN MONOHYDRATE

Capsules

250mg & 500mg

Y

CEFALEXIN MONOHYDRATE

Suspension

250mg/5mL

Y

CEFAZOLIN

Eye drop

5%

R

Restricted to eye clinic (Manufactured at RDH).

Blanket outpatient approval for treatment or prevention of ophthalmic infections.

CEFAZOLIN

Injection

1g

Y

CEFAZOLIN

Infusor

Y

CEFEPIME

Injection

1g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFIDEROCOL

Injection

1g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Prescribing to be restricted to Infectious disease (IFD) in susceptible infections for patients in whom other alternatives are inappropriate

CEFOTAXIME

Injection

1g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFOXITIN

Infusor

1g & 12g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFTAROLINE

Injection

600mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFTAZIDIME

Injection

1g & 2g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFTAZIDIME

24 hour Infusor

2g, 3g, 4g, 5g & 6g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFTAZIDIME/AVIBACTAM

Injection

2g/0.5g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Prescribing to be restricted to Infectious disease (IFD) in susceptible infections for patients in whom other alternatives are inappropriate

CEFTRIAXONE

Infusor

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFTRIAXONE

Injection

1g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFUROXIME

Tablet

250mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CEFUROXIME

Suspension

125mg/5mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CELECOXIB

Capsule

100mg & 200mg

Y

CETIRIZINE

Tablet

10mg

R

For patients who fail to respond to loratadine. Restricted to dermatology and immunology.

CETOMACROGOL

Cream

100g

Y

CETUXIMAB

Injection

100mg/20mL & 500mg/100mL

R

Restricted to Haematology and Oncology for PBS listed indications.

CHLORAL HYDRATE

Solution

1g/10mL

Y

CHLORAMBUCIL

Tablet

2mg

Y

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

CHLORAMPHENICOL

Injection

1g

R

Restricted to ICU and IFD only.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

CHLORAMPHENICOL (Chlorsig®)

Eye ointment

1%

Y

CHLORAMPHENICOL (Chlorsig®)

Eye Drops

0.50%

Y

CHLORHEXIDINE

Obstetric cream

1%

Y

CHLORHEXIDINE

Mouth wash

0.20%

Y

CHLORHEXIDINE 3mg/PHENYLEPHRINE 2.5mg

Nasal Ointment

0.3%/0.25%

Y

CHLORHEXIDINE IN ALCOHOL 70%

Solution

0.50%

Y

CHLORHEXIDINE SCRUB

Medisponge

Y

CHLORHEXIDINE/ CETRIMIDE

Irrigation

0.015/0.15%

Y

CHLORHEXIDINE/ CETRIMIDE

Solution

0.015/0.15%

Y

CHLORHEXIDINE/ CETRIMIDE

Cream

0.1%/0.5%

Y

CHLORPROMAZINE

Injection

50mg/2mL

Y

CHLORPROMAZINE

Tablet

10mg, 25mg & 100mg

Y

CHLORPROMAZINE

Syrup

25mg/5mL

Y

CHOLINE SALICYLATE/CETALKONIUM CHLORIDE/MENTHOL (Sedagel®)

Dental Gel

8.7%/0.01%/0.057%

Y

CICLOSPORIN

Injection

50mg/mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

CICLOSPORIN

Capsule

10mg, 25mg, 50mg & 100mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

CINACALCET

Tablet

30mg, 60mg & 90mg

R

Restricted to nephrologists for patients who meet the PBS criteria

CINCHOCAINE & HYDROCORTISONE (Proctosedyl®)

Suppositories

5mg/5mg

Y

CINCHOCAINE & HYDROCORTISONE (Proctosedyl®)

Ointment

0.5%/0.5%

Y

CINCHOCAINE & ZINC OXIDE (Rectinol®)

Ointment

0.5%/20%

Y

CIPROFLOXACIN

Ear Drops

0.30%

Y

CIPROFLOXACIN

Tablet

250mg, 500mg & 750mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for susceptible infections not listed on the PBS approved by Infectious Diseases.

CIPROFLOXACIN

Injection

200mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CIPROFLOXACIN/ HYDROCORTISONE (CIPROFLOXACIN CO®)

Ear Drops

0.2%/1%

Y

CISPLATIN

Injection

100mg/100mL & 50mg/50mL

R

Restricted to Haematology and Oncology for PBS listed indications.

CITALOPRAM

Tablet

20mg

Y

CLADRIBINE

Injection

10mg/10mL & 10mg/5mL

R

Restricted to Haematology and Oncology for PBS listed indications.

CLARITHROMYCIN

Tablet

250mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for susceptible infections not listed on the PBS approved by Infectious Diseases.

CLINDAMYCIN

Capsule

150mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CLINDAMYCIN

Solution

75mg/5mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Use restricted to discharge and outpatients only.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

CLINDAMYCIN

Injection

600mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

CLOFAZAMINE/ DAPSONE/ RIFAMPICIN (LEPROSY PACK)

Capsules & Tablets

300mg/100mg/ 100mg

R

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

CLONAZEPAM

Injection

1mg

Y

Blanket outpatient approval for Palliative care patients.

CLONAZEPAM

Solution

2.5mg/mL

Y

Blanket outpatient approval for Palliative care patients.

CLONAZEPAM

Tablet

500mcg & 2mg

Y

Blanket outpatient approval for Palliative care patients.

CLONIDINE

Injection

150mcg/1mL

Y

CLONIDINE

Tablet

100mcg & 150mcg

Y

CLOPIDOGREL

Tablet

75mg

Y

CLOTRIMAZOLE

Pessary

500mg

Y

CLOTRIMAZOLE

Vaginal Cream

1%

Y

CLOTRIMAZOLE

Cream

1%

Y

CLOVE OIL BP

Oil

10mL

Y

CLOZAPINE

Tablet

25mg, 50mg, 100mg & 200mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

COAL TAR

Solution

200mL

Y

COBICISTAT, ELVITEGRAVIR, EMTRICITABINE & TENOFOVIR ALAFENAMIDE

Tablet

150mg+150mg+

200mg+10mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

COCAINE

Solution

10%

Y

CODEINE PHOSPHATE

Tablet

30mg

Y

COLCHICINE

Tablet

500mcg

Y

COLECALCIFEROL

Capsule

1000 units

Y

COLECALCIFEROL

Oral Solution

5000 units / mL

Y

COLESTYRAMINE LIGHT

Sachets

4g

Y

Colistimethate Sodium (Colistin)

Injection

150mg/2ml

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

COLLOIDAL OATMEAL (DermaVeen®)

Lotion

20mg/g

R

Restricted to burns unit & wound clinic

COMBINATION ANTACIDS

Suspension

Tablet

Y

CONJUGATED ESTROGENS

Tablet

300microg & 625microg

Y

CORTISONE ACETATE

Tablet

5mg & 25mg

Y

COVID MEDICINES

-

-

R

Blanket approval for all medicines listed in the National Living COVID Guidelines.

Blanket approval for prescribers to use Clinical Excellence Commission (CEC) resources available at: COVID-19 Resources - NSW Therapeutic Advisory Group (nswtag.org.au) and

Medication Safety Updates - Clinical Excellence Commission (nsw.gov.au)

CROTAMITON

Cream

10%

Y

CYCLIZINE

Injection

50mg/mL

R

Restricted to Anaesthetics and Palliative Care for the treatment of postoperative nausea and vomiting, and nausea and vomiting in the palliative care setting.

Blanket outpatient approval for prevention of nausea and vomiting in Palliative Care patients.

CYCLOPENTOLATE

eye drop & Minims

1%

Y

CYCLOPENTOLATE

Minims

0.50%

Y

CYCLOPHOSPHAMIDE

Infusor

Y

CYCLOPHOSPHAMIDE

Injection

500mg, 1gram & 2gram

Y

CYCLOPHOSPHAMIDE

Tablet

50mg

Y

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

CYPROTERONE

Tablet

50mg

Y

CYTARABINE

Injection

100mg/5mL

R

Restricted to Haematology and Oncology for PBS listed indications.

DABRAFENIB

Capsules

50mg, 75mg

R

Restricted to Haematology and Oncology for PBS listed indications.

DACARBAZINE

Infusion

R

Restricted to Haematology and Oncology for Metastatic Melanoma and Hodgkin’s Lymphoma.

DACTINOMYCIN

Injection

R

Restricted to Haematology and Oncology for Low Risk Gestational Trophoblastic Disease.

DANTROLENE

Injection

20mg

Y

DANTROLENE

Capsules

25mg & 50mg

Y

DAPAGLIFLOZIN

TABLET

10mg

Y

DAPSONE

Tablet

100mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

DAPTOMYCIN

Injection

500mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

DARBEPOETIN ALFA

Injection

10mcg, 20mcg, 30mcg, 40mcg, 60mcg, 80mcg, 100mcg & 150mcg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DARUNAVIR

Tablet

600mg & 800mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DARUNAVIR & COBICISTAT

Tablet

800mg+150mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DARUNAVIR, COBICISTAT, EMTRICITABINE & TENOFOVIR ALAFENAMIDE

Tablet

800mg+150mg+

200mg+10mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DAUNORUBICIN MINIBAG

Injection

R

Restricted to Haematology and Oncology for Acute Myeloid Leukaemia.

DEFERASIROX (JADENU®)

tablets

90mg, 180mg & 360mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DEGARELIX

Injection

80mg & 120mg

R

Restricted for PBS listed indications.

Blanket approval for outpatient supply with PBS prescription.

DENOSUMAB

Injection

60mg & 120mg

R

Restricted to Haematology and Oncology for PBS listed indications.

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

DESFERASIOXAMINE

Injection

2g

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DESFLURANE

Solution

240mL

Y

DESLORATADINE

Liquid

2.5mg/5mL

Y

DESMOPRESSIN

Injection

4mcg

Y

DESMOPRESSIN

Nasal Solution

100mcg/mL

Y

DESMOPRESSIN

Tablet

200mcg

Y

DESMOPRESSIN

Nasal Spray

10mcg/dose

Y

DEXAMETHASONE

eye drop

0.10%

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

DEXAMETHASONE

Tablet

500mcg & 4mg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

DEXAMETHASONE

Liquid

1mg/mL

Y

DEXAMETHASONE

Injection

4mg & 8mg

Y

DEXAMETHASONE, FRAMYCETIN & GRAMICIDIN (Sofradex®/Otodex®)

Ear Drops

0.05%/ 0.5%/ 0.005%

Y

DEXAMFETAMINE

Tablet

5mg

R

Use in attention deficit hyperactivity disorder

DEXCHLORPHENIRAMINE

Tablet

2mg

Y

DEXMEDETOMIDINE

Injection

200mcg/2mL

R

Restricted to ICU, Palliative Care and Anaesthetics only

DIAZEPAM

Suspension

10mg/10mL

Y

DIAZEPAM

Rectal Solution

5mg/5mL

Y

DIAZEPAM

Tablet

2mg & 5mg

Y

DIAZEPAM

Injection

10mg

Y

DIAZOXIDE

Tablet

25mg

R

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

DICLOFENAC

Enteric Coated Tablet

25mg & 50mg

Y

DICLOFENAC

Gel

1%

Y

DICLOFENAC

Suppositories

100mg

Y

DICLOXACILLIN

Capsule

250mg & 500mg

Y

DIGOXIN

Suspension

250mcg/5mL

Y

DIGOXIN

Tablet

62.5mcg & 250mcg

Y

DIGOXIN

Injection

50mcg & 500mcg

Y

DIGOXIN-SPECIFIC ANTIBODY (DigiFab®)

Injection

40mg

R

This medication is restricted to ED, ICU and CCU for the treatment of digoxin toxicity, or for other cardiac glycoside poisoning such as Oleander and Bufotoxin (cane toad).

DILTIAZEM

Modified release Capsules

180mg, 240mg & 360mg

Y

DILTIAZEM

Tablet

60mg

Y

DIMERCAPROL

Injection

200mg

R

Stock held by RDH Emergency Department for treatment of severe lead poisoning.

DIMETHICONE (Hedrin 15®)

Gel Spray

4%

Y

DIMETHICREAM

Cream

100g

Y

DINOPROSTONE

Vaginal Gel

1mg & 2mg

R

Restricted to Specialist Obstetricians and their Registrars for induction of labour according to local guidelines.

DINOPROSTONE CR

Controlled Release Pessary

10mg

R

Restricted to Specialist Obstetricians and their Registrars for induction of labour according to local guidelines.

DIPHENOXYLATE & ATROPINE (Lomotil®)

Tablet

2.5/0.025mg

Y

DIPHTHERIA & TETANUS VACCINE (ADT®)

Injection

Y

DIPHTHERIA TETANUS & PERTUSSIS VACCINE (Boostrix®)

Injection

Y

DIPHTHERIA, TETANUS, PERTUSSIS & POLIO (Infanrix-IPV®)

Injection

Y

DISODIUM EDETATE

Injection

3%

Y

DOBUTAMINE

Injection

250mg

Y

DOCETAXEL

Injection

20mg, 80mg & 160mg

R

Restricted to Haematology and Oncology for PBS listed indications.

DOCUSATE & SENNA (Coloxyl & Senna®)

Tablet

50/8mg

Y

DOCUSATE SODIUM

Tablet

50mg & 120mg

Y

DOCUSATE SODIUM EAR DROPS (Waxsol®)

Ear Drops

Y

DOLUTEGRAVIR

Tablet

50mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DOLUTEGRAVIR, ABACAVIR & LAMIVUDINE

Tablet

50mg+600mg+

300mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DOLUTEGRAVIR & LAMIVUDINE

Tablet

50mg+300mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DOLUTEGRAVIR & RILPIVIRINE

Tablet

50mg+25mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

DOMPERIDONE

Tablet

10mg

Y

Blanket outpatient approval for the stimulation of lactation.

DONEPEZIL

Tablet

5mg & 10mg

Y

DOPAMINE

Injection

200mg

Y

DORNASE ALFA

Nebulised solution

2.5mg/2.5mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Restricted for use by with respiratory specialists/advanced trainees with experience in its use for empyema management.

DOSULEPIN (DOTHIEPIN)

Tablet

75mg

Y

DOSULEPIN (DOTHIEPIN)

Capsule

25mg

Y

DOXORUBICIN

Injection

50mg/25mL & 200mg/100mL

R

Restricted to Haematology and Oncology for PBS listed indications.

DOXORUBICIN LIPOSOMAL

Injection

20mg/10mL & 50mg/25mL

R

Restricted to Haematology and Oncology for PBS listed indications.

DOXYCYCLINE

Tablet

100mg

Y

Blanket outpatient approval for melioidosis eradication in patients who cannot tolerate trimethoprim/sulfamethoxazole approved by IFD.

DOXYCYCLINE

Injection

100mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

DOXYLAMINE

Tablets

25mg

Y

DROPERIDOL

Injection

2.5mg/1mL 10mg/2mL

Y/ R

10mg/2mL restricted to Emergency Departments and Mental Health

DULAGLUTIDE

Syringe

1.5mg

R

Restricted to PBS indications

(Use restricted to continuation treatment only; Treatment initiation requires IPU approval)

DULOXETINE

Capsules

30mg & 60mg

R

Restricted to PBS indications.

DUTASTERIDE/TAMSULOSIN

Capsules

500mcg/400mcg

R

Restricted to PBS indications.

ECULIZUMAB

Injection

300mg/30mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Note: Eculizumab is reimbursed by the PBS under S100 HSD arrangements for both outpatients and public hospital admitted patients for the treatment of aHUS.

EDROPHONIUM

Injection

10mg

Y

EFAVIRENZ

Tablet

200mg & 600mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

EMICIZUMAB

Syringe

30mg/mL

60mg/0.4mL

105mg/0.7mL &

150mg/1mL

R

Restricted to inpatient and outpatient Haematology patients that meet the National Product List (NPL) restrictions.

EMPAGLIFLOZIN

Tablet

10mg & 25mg

Y

EMTRICITABINE, RILPIVIRINE & TENOFOVIR ALAFENAMIDE

Tablet

200mg+25mg+25mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

EMTRICITABINE & TENOFOVIR ALAFENAMIDE

Tablet

200mg+25mg & 200mg+10mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ENALAPRIL

Tablet

5mg, 10mg, 20mg

Y

For paediatric patients with heart failure or breastfeeding women with hypertension or heart failure

ENOXAPARIN

Injection

20mg, 40mg, 60mg, 80mg 100mg, 120mg & 150mg

Y

ENTECAVIR

Tablet

500mcg & 1mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Blanket outpatient approval for the prevention of hepatitis B virus reactivation or progression in patients >16 years old who are immunosuppressed or live in a remote area and do not meet PBS criteria restricted to prescribers under the direction of Infectious Diseases or Liver Clinic Specialists.

EPHEDRINE

Injection

30mg

Y

EPIRUBICIN

Injection

2mg/mL

R

Restricted to Oncology/Haematologist use only

EPLERENONE

Tablet

25mg & 50mg

R

Restricted to Cardiology

EPOPROSTENOL

Injection

500 mcg & 1.5mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

EPTACOG ALPHA (NovoSeven RT®)

Injection

1mg & 2mg

R

Available at RDH only. Restricted to ICU, stock is kept in ICU. 1.2mg strength is non-formulary and stock is supplied by blood transfusion services for Haematology protocol use.

ERGOMETRINE

Injection

500mcg

Y

ERGOMETRINE & OXYTOCIN

Injection

500mcg/5 IU

Y

ERLOTINIB

Tablet

25mg, 100mg & 150mg

R

Restricted to Haematology and Oncology for PBS listed indications.

ERTAPENEM

Injection

1g

Y

ERYTHROMYCIN

Capsule

250mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

ERYTHROMYCIN ETHYL SUCCINATE

Suspension

200mg/5mL

Y

ERYTHROMYCIN LACTOBIONATE

Injection

1g

Y

ESCITALOPRAM

Tablets

10mg & 20mg

R

PBS indications only.

ESMOLOL

Injection

100mg/10mL

Y

ESTRIOL (ESTRADIOL VALERATE)

Tablet

1mg

Y

ESTRIOL (ESTRADIOL)

Patch

25mcg, 50mcg & 100mcg

Y

ESTRIOL (ESTRADIOL)

Implant

100mg

Y

ESTRIOL (ESTRIOL)

Vaginal Cream

1mg/g

Y

ETANERCEPT

Injection

25mg

Y

ETHAMBUTOL

Tablet

100mg & 400mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of Tuberculosis approved by TB clinic/IFD.

ETONOGESTREL (Implanon NXT®)

Implant

68mg

R

Restricted to:

O&G use for inpatients where access to Implanon NXT® insertion in primary care is not appropriate or not available

or

Paediatricians (for TEHS only) for high risk adolescents

ETOPOSIDE

Capsule

50mg & 100mg

R

Restricted to Haematology and Oncology for PBS listed indications.

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

ETOPOSIDE

Injection

100mg & 1gram

R

Restricted to Haematology and Oncology for PBS listed indications.

ETRAVIRINE

Tablet

200mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

EVEROLIMUS

Tablet

500mcg & 750mcg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

EXEMESTANE

Tablet

25mg

Y

EZETIMIBE

Tablet

10mg

R

Restricted for use in patients who are on an HMG CoA reductase inhibitor (statin) in patients whose cholesterol levels are inadequately controlled

FAMOTIDINE

Tablet

20mg & 40mg

Y

FENOFIBRATE

Tablet

48mg & 145mg

Y

FENTANYL

Injection

100mcg & 500mcg

Y

FENTANYL

Patch

12mcg, 25mcg, 50mcg, 75mcg & 100mcg

Y

FENTANYL (ABSTRAL®)

Sublingual Tablets

100mcg, 300mcg & 400mcg

R

Restricted to Palliative Care as per the PBS Criteria

FERRIC CARBOXYMALTOSE (IRON)

Injection

500mg/10mL & 100mg/2mL

R

Restricted to use in remote health according to approved protocol. All stock to be dispensed from pharmacy on an individual patient basis.

Restricted to use in outpatients who are able to access supply via a PBS prescription (500mg/10mL strength only).

Restricted to use in inpatients for the following indications;

Previously documented adverse drug reaction to iron polymaltose.

Heart failure with a documented fluid restriction.

FERRIC DERISOMALTOSE (IRON)

Injection

500mg/5mL

R

Restricted to use in outpatients who are able to access supply via a PBS prescription.

Restricted to use in inpatients for the following indications for patients requiring more than 1000mg of elemental iron:

Previously documented adverse drug reaction to iron polymaltose.

Heart failure with a documented fluid restriction.

FERRIC SUBSULPHATE (IRON)

Gel

21%

R

Restricted to gynaecology use only.

FERROUS FUMARATE & FOLIC ACID (Ferro-F®)

Modified Release Tablets

310mg/350mcg

Y

FERROUS SULFATE HEPTAHYDRATE

Liquid

150mg/5mL

Y

FERROUS SULFATE HEPTAHYDRATE & VITAMIN C

Modified Release Tablets

325mg/500mg

Y

FERROUS SULFATE HEPTAHYDRATE (Ferrograd®)

Tablet

325mg

Y

FILGRASTIM

Injection

300mcg & 480mcg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

FLECAINIDE

Injection

150mg

Y

FLECAINIDE

Tablet

50mg & 100mg

Y

FLUCLOXACILLIN

Injection

500mg & 1g

Y

FLUCLOXACILLIN

Infusor

4g, 6g, 8g & 12g

Y

FLUCLOXACILLIN

Suspension

250mg/5mL

Y

FLUCONAZOLE

Capsule

50mg, 100mg & 200mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Restricted to Haematology and Oncology for PBS listed indications.

Blanket outpatient approval for susceptible infections not listed on the PBS approved by Infectious Diseases and for antifungal prophylaxis in haematological malignancies with immunosuppressive chemotherapy.

FLUCONAZOLE

Injection

100mg & 200mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Restricted to Haematology and Oncology for PBS listed indications.

FLUCONAZOLE

Suspension

50mg/5mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Restricted to Haematology and Oncology for PBS listed indications.

FLUCYTOSINE

Capsule

500mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

FLUDARABINE

Injection

50mg

R

Restricted to Haematology and Oncology for PBS listed indications.

FLUDARABINE

Tablet

10mg

R

Restricted to Haematology and Oncology for PBS listed indications.

FLUDROCORTISONE

Tablet

100mcg

Y

FLUMAZENIL

Injection

500mcg

Y

FLUORESCEIN

Strips

1mg

Y

FLUORESCEIN SODIUM

Minims

2%

Y

FLUORESCEIN SODIUM

Injection

10%

Y

FLUOROMETHOLONE (Flucon®)

Eye drops

0.10%

R

Restricted to Ophthalmologist use only

FLUOROMETHOLONE ACETATE (Flarex®)

Eye drops

0.10%

R

Restricted to Ophthalmologist use only

FLUOROURACIL

Infusion

R

Restricted to Haematology and Oncology for PBS listed indications.

FLUOROURACIL

Injection

500mg, 1gram, 2.5gram & 5gram

R

Restricted to Haematology and Oncology for PBS listed indications.

FLUOXETINE

Capsule & Dispersible tablets

20mg

R

Dispersible tablets are restricted to Paediatrics and Mental Health

FLUPENTHIXOL DECANOATE

Injection

20mg, 40mg & 100mg

Y

*Order on request

FLUTICASONE

Inhaler

125mcg, 250mcg & 50mcg

Y

FLUTICASONE & SALMETEROL (Seretide®)

Accuhaler

100/50mcg, 250/50mcg & 500/50mcg

Y

FLUTICASONE & SALMETEROL (Seretide®)

Inhaler

50/25mcg, 125/25mcg & 250/25mcg

Y

FLUTICASONE / VILANTEROL (Ellipta Breo®)

Inhaler

100mcg/25mcg, 200mcg/25mcg

Y

FOLIC ACID

Injection

15mg

Y

FOLIC ACID

Tablet

500mcg & 5mg

Y

Blanket outpatient approval for prevention of sulfamethoxazole/trimethoprim induced folate deficiency in patients receiving treatment for melioidosis.

FONDAPARINUX

Injection

2.5mg/0.5mL

R

Restricted to use by ICU and Haematology for Heparin Inducted Thrombocytopenia/Thrombosis (HIT).

FORMALIN

Solution

10%

Y

FOSAMPRENAVIR

Tablet

700mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

FOSAPREPITANT

Injection

150mg

R

Restricted to Haematology and Oncology for PBS listed indications in patients who cannot tolerate orals

FOSFOMYCIN

Granules for Solution

3g Sachet

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for multi-resistant UTI approved by IFD

FOSFOMYCIN

Injection

4g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

FOTEMUSTINE

Injection

208mg

R

Restricted to Haematology and Oncology for PBS listed indications.

FUROSEMIDE

Solution (SyrSpend®)

50mg/5mL

Y

PBS 20mg tablets should be prescribed where doses can be divided into 5mg increments.

Blanket outpatient approval for paediatrics where the dose is not in 5mg increments.

FUROSEMIDE

Injection

20mg & 250mg

Y

FUROSEMIDE

Tablet

20mg, 40mg & 500mg

Y

GABAPENTIN

Capsule

100mg, 300mg, 400mg & 800mg

Y

Blanket outpatient approval for the treatment of neuropathic pain.

GANCICLOVIR

Injection

500mg

S

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

GEFITINIB

Tablet

250mg

R

Restricted to Haematology and Oncology for PBS listed indications.

GEMCITABINE

Injection

200mg, 1g & 2g

R

Restricted to Haematology and Oncology for PBS listed indications.

GENTAMICIN

Injection

80mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

GENTAMICIN/CITRATE

Syringe

10mg/31.3mg

Y

GLECAPREVIR/PIBRENTASVIR (Maviret®)

Tablets

100/40mg

S

Restricted to specialists working in the liver clinic running the HCV treatment program. For initiation in outpatients via the Highly specialised Drugs Program (Section 100). Refer to PBS Criteria.

GLICLAZIDE

Modified release tablets

30mg

Y

GLICLAZIDE

Modified release tablets

60mg

R

For discharge prescriptions only

GLICLAZIDE

Tablet

80mg

Y

GLIMEPIRIDE

Tablet

1mg, 2mg & 4mg

Y

GLUCAGON

Injection

1mg

Y

GLUCOSE

Injection

10%

Y

GLUCOSE

Injection

5% - 500mL & 1L

Y

GLUCOSE

Injection & mini-jet

50% - 50mL, 500mL

Y

Mini-jet is restricted to resuscitation room in the emergency department

GLUCOSE & SODIUM CHLORIDE

2.5%/0.45%, 4%/0.18%

500mL & 1L

Y

GLUCOSE & SODIUM CHLORIDE

5%/0.9%

1L

Y

GLUCOSE TOLERANCE TEST

Solution

75g

Y

GLYCEROL

Suppositories

700mg, 2.8g

Y

GLYCEROL BP

Solution

200mL

Y

GLYCERYL TRINITRATE

Sublingual Tablet

300mcg, 600mcg

Y

*300mcg added for short-term listing while 600mcg is out of stock.

GLYCERYL TRINITRATE

Ointment

0.20%

Y

GLYCERYL TRINITRATE

Spray

400mcg

Y

GLYCERYL TRINITRATE

Patch

5mg/24 hour & 10mg/24 hour

Y

GLYCERYL TRINITRATE

Injection

50mg

Y

GLYCINE

Irrigation

1.50%

Y

GLYCOPYRRONIUM BROMIDE

Injection

200mcg

Y

Blanket outpatient approval for Palliative care patients.

GOSERELIN

Implant

3.6mg & 10.8mg

R

Restricted to PBS listed indications AND for Ovarian Suppression with chemotherapy (3.6mg only).

Blanket approval for outpatient supply with PBS prescription.

GRAMICIDIN/NEOMYCIN/NYSTATIN/TRIAMCINOLONE ACETONIDE (Otocomb Otic®)

Ear Ointment

0.25mg/2.5mg/100,000 units/1mg/g

Y

GRANISETRON

Tablet

2mg

R

Restricted to Haematology and Oncology for PBS listed indications (outpatient/same day admission only).

GRISEOFULVIN

Tablet

125mg & 500mg

Y

HAEMOFILTRATION (CITRATE)

Solution

R

Restricted to ICU only

HAEMOFILTRATION LACTATE FREE

Solution

R

Restricted to ICU only

HAEMOPHILUS INFLUENZA B VACCINE

Injection

Y

HALOPERIDOL

Tablet

500mcg, 1.5mg & 5mg

Y

HALOPERIDOL

Injection

5mg

Y

Blanket outpatient approval for Palliative care patients.

HALOPERIDOL

Solution

10mg/5mL

Y

HALOPERIDOL DECANOATE

Injection

50mg

Y

HEPARIN SODIUM

Injection

5000units/0.2mL, 5000units/5mL, 25000units/5mL

Y

HEPARINISED SALINE

Injection

50units/5mL

Y

HEPARINOIDS (HEPARINOID CREAM)

Cream

0.3%

Y

HEPATITIS A VACCINE

Injection

Y

HEPATITIS A&B VACCINE

Injection

Y

HEPATITIS B VACCINE (ADULT)

Injection

Y

Available brands:

H-B-Vax II (Adult)® or Engerix B (Adult)®

HEPATITIS B VACCINE (PAEDIATRIC)

Injection

Y

Available brands:

H-B-Vax II (Paediatric)® or Engerix B (Paediatric)®

HEPATITIS B VACCINE (DIALYSIS FORMULATION)

Injection

Y

Available brands:

H-B-Vax II (Dialysis formulation)®

HEPATITIS B, Hib & POLIO (Infanrix-Hexa®)

Injection

Y

HEPATITIS-B VACCINE (DIALYSIS)

Injection

40mcg/mL

Y

HUMAN PAPILLOMAVIRUS (HPV) VACCINE

Injection

Y

HYALURONIDASE

Injection

1500 u

Y

HYDRALAZINE

Injection

20mg

Y

HYDRALAZINE

Tablet

25mg & 50mg

Y

HYDROCHLORIC ACID

Injection

2M

Y

HYDROCHLOROTHIAZIDE

Tablet

25mg

Y

HYDROCORTISONE

Ointment

1%

Y

HYDROCORTISONE

Cream

1%

Y

HYDROCORTISONE

Tablet

4mg & 20mg

Y

HYDROCORTISONE

Eye ointment

1%

Y

HYDROCORTISONE

Foam

10%

Y

HYDROCORTISONE SODIUM SUCCINATE

Injection

100mg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

HYDROCORTISONE/ CLOTRIMAZOLE

Cream

1%

Y

HYDROGEN PEROXIDE

Solution

3%

Y

HYDROMORPHONE

Tablet

2mg, 4mg & 8mg

R

Restricted to Palliative Care, Rehabilitation and Pain teams only

HYDROMORPHONE

Liquid

5mg/5mL

R

Restricted to Palliative Care, Rehabilitation and Pain teams only

HYDROMORPHONE

Injection

2mg, 10mg & 50mg

R

Restricted to Palliative Care, Rehabilitation and Pain teams only.

Blanket outpatient approval for chronic pain in palliative care patients.

HYDROXOCOBALAMIN

Injection

1000mcg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

HYDROXYCHLOROQUINE

Tablet

200mg

Y

HYDROXYCARBAMIDE (HYDROXYUREA)

Capsule

500mg

Y

HYOSCINE BUTYLBROMIDE

Injection

20mg

Y

Blanket outpatient approval for Palliative care patients.

HYOSCINE BUTYLBROMIDE

Tablet

10mg

Y

HYOSCINE HYDROBROMIDE

Injection

400mcg

Y

Blanket outpatient approval for excess respiratory tract secretions.

HYOSCINE HYDROBROMIDE

Tablet

300mcg

R

For the treatment of hypersalivation restricted to inpatients who have clozapine induced sialorrhoea (CIS).

HYPERTONIC SALINE

Inhalation

6%

R

Restricted to cystic fibrosis (CF) or non-CF bronchiectasis in paediatric patients.

Blanket approval for outpatient supply to CF or non-CF bronchiectasis in paediatric patients.

HYPROMELLOSE

Eye drop

0.50%

Y

HYPROMELLOSE/ CARBOMER GEL (Genteal®)

Eye drop

3mg/2mg

Y

IBUPROFEN

Injection

10mg

Y

IBUPROFEN

Tablet

200mg & 400mg

Y

IBUPROFEN

Syrup

100mg/5mL

Y

ICATIBANT ACETATE

Pre-filled Syringe

30mg/3mL

R

Restricted to Emergency Medicine consultants under the advice of the duty immunologist for the emergency treatment of:

Alteplase induced angioedema;

Severe angioedema affecting the airway due to ACE inhibitors;

Symptomatic treatment of acute attacks of hereditary angioedema in adults with C1 esterase inhibitor deficiency.

IDARUBICIN

Injection

5mg & 10mg

R

Restricted to Haematology and Oncology for PBS listed indications.

IDARUBICIN

Capsules

5mg & 10mg

R

Restricted to Haematology and Oncology for PBS listed indications AND for Myeloma.

IFOSFAMIDE

Injection

1gram & 2gram

R

Restricted to Haematology and Oncology for PBS listed indications.

ILOPROST

Injection

20mcg/2mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

INCREMIN IRON MIXTURE

Mixture

Y

INDAPAMIDE

Modified Release Tablets

1.5mg

Y

INDOMETHACIN

Capsule

25mg

Y

INDOMETHACIN

Injection

1mg

Y

INDOMETHACIN

Suppositories

100mg

Y

INFLIXIMAB

Injection

100mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

INFLUENZA VACCINE

Injection

60 microg/0.5mL

Y

INSULIN ASPART Injection (NovoRapid®)

Flexpen (3mL), Penfill (3mL) & Vial (10mL)

100 units/mL

Y

INSULIN ASPART PROTAMINE 70 units/mL + INSULIN ASPART 30 units/mL Injection (Novomix 30 ®)

Flexpen (3mL) & Penfill (3mL)

100 units/mL

Y

INSULIN ASPART 30 units/mL + INSULIN DEGLUDEC 70 units/mL injection (Ryzodeg® 70/30)

Flexpen (3mL) & Penfill (3mL)

100 units/mL

Y

INSULIN GLARGINE Injection (Lantus®/Optisulin®)

Penfill & Vial

100 units/mL

Y

INSULIN ISOPHANE Injection (Protaphane®)

Vial, Innolet, Novolet and Penfill

100 units/mL

Y

INSULIN ISOPHANE NPH Injection (Humulin NPH®)

Penfill

100 units/mL

R

To be used second line when other formulary insulin products are not suitable, or as continuing therapy for patients commenced in the community.

INSULIN LISPRO Injection (Humalog®)

Penfill,

Kwik Pen

100 units/mL

R

To be used second line when other formulary insulin products are not suitable, or as continuing therapy for patients commenced in the community.

INSULIN LISPRO 25 units/mL /INSULIN LISPRO PROTAMINE 75 units/mL Injection (Humalog 25®)

Flexpen (3mL) & Penfill (3mL)

100 units/mL

R

To be used second line when other formulary insulin products are not suitable, or as continuing therapy for patients commenced in the community.

INSULIN NEUTRAL (Actrapid®)

Penfill & Vial

100 units/mL

Y

INSULIN NEUTRAL/ ISOPHANE (Mixtard 30/70®)

Vial, Innolet & Penfill

100 units/mL

Y

IODINE/POTASSIUM IODIDE (Lugol’s®)

Solution (100mL)

5%/10% w/v

Y

IPILIMUMAB

Injection

213mg

R

For oncologist use only - restricted to patients eligible for compassionate supply programme.

IPILIMUMAB

Injection

50mg & 200mg

R

Restricted to Haematology and Oncology for PBS listed indications.

IPRATROPIUM

Inhaler

21microg

Y

IPRATROPIUM

nebulised solution

500microg

Y

IRBESARTAN

Tablet

75mg, 150mg & 300mg

Y

IRBESARTAN &HYDROCHLOROTHIAZIDE

Tablet

150/12.5mg & 300/12.5mg

Y

IRINOTECAN

Injection

40mg, 100mg & 500mg

R

Restricted to Haematology and Oncology for PBS listed indications.

IRON POLYMALTOSE

Injection

100mg

Y

ISOFLURANE

Liquid for inhalation

Y

ISONIAZID

Tablet

100mg & 300mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of active or latent tuberculosis by TB clinic/IFD.

ISONIAZID & RIFAMPICIN

Tablet

50mg + 75mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of active or latent tuberculosis by TB clinic/IFD.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

ISONIAZID & RIFAMPICIN

Tablet

75mg + 150mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of active or latent tuberculosis by TB clinic/IFD.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

ISONIAZID & RIFAPENTINE

Tablet

300mg + 300mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of latent tuberculosis by TB clinic/IFD.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

ISONIAZID, PYRAZINAMIDE & RIFAMPICIN

Tablet

50mg +150mg + 75mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of active or latent tuberculosis by TB clinic/IFD.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

ISONIAZID, ETHAMBUTOL, PYRAZINAMIDE & RIFAMPICIN

Tablet

75mg + 275mg + 400mg + 150mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of active or latent tuberculosis by TB clinic/IFD.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

ISOPRENALINE

Injection

200mcg

Y

ISOPROPYL ALCOHOL BP

Solution

Y

ISOSORBIDE DINITRATE

Sublingual Tablet

5mg

Y

ISOSORBIDE MONONITRATE

Modified Release Tablets

60mg

Y

ITRACONAZOLE

Solution

50mg/5mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

ITRACONAZOLE (LOZANOC®)

Capsule

50mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

IVABRADINE

Tablet

5mg & 7.5mg

R

Restricted to Cardiologists for treatment of Chronic heart failure for patients that meet the PBS criteria.

Restricted to Cardiology for use in patients with a heart rate greater than 60 beats per minute prior to computed tomography coronary angiography (CTCA) when beta blockers and/or calcium channel blockers are contraindicated or insufficient.

IVERMECTIN

Tablet

3mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

KETAMINE

Injection

200mg

Y

KETAMINE

Wafer

25mg

R

Restricted to use by RDH Acute Pain Service (APS) as an analgesic agent for painful procedures on the ward.

KETOCONAZOLE

Shampoo

2%

Y

KETOROLAC

Injection

30mg

Y

KETOROLAC

Eye drop

0.50%

Y

KIDNEY PERFUSION

Infusion

R

Restricted for kidney harvesting

LABETALOL

Tablet

100mg

Y

LABETALOL

Injection

50mg/10mL

R

Restricted to ICU/OT for severe pre-eclampsia - refer to protocol on the PGC.

Restricted to ED/ICU for the management of hypertension in Stroke Thrombolysis or Pulmonary Embolism thrombolysis – refer to protocols on the PGC.

LACTASE

Drops

Y

LACTULOSE

Syrup

Y

LAMIVUDINE

Solution

10mg/mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

LAMIVUDINE

Tablet

100mg, 150mg & 300mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

LAMIVUDINE & ZIDOVUDINE

Tablet

150mg+300mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

LAMOTRIGINE

Tablet

5mg, 25mg, 50mg & 100mg

Y

LANOLIN BP

Ointment

5gram

Y

LANREOTIDE

Injection

60mg & 90mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

LATANOPROST

Eye drop

50mcg

Y

LENALIDOMIDE

Capsule

5mg, 10mg, 15mg & 25mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

LETROZOLE

Tablet

2.5mg

R

Restricted to Haematology and Oncology

LEUCOVORIN

Tablet

15mg

R

Restricted to Haematology and Oncology for PBS listed indications.

LEUCOVORIN

Injection

50mg, 100mg, 300mg & 1gram

R

Restricted to Haematology and Oncology for PBS listed indications.

LEVAMISOLE

Tablets

50mg

R

Blanket outpatient/inpatient approval. Restricted to Paediatric nephrologists.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

LEVETIRACETAM

Injection

500mg/5mL

Y

LEVETIRACETAM

Solution

500mg/5mL

Y

LEVETIRACETAM

Tablet

250mg, 500mg & 1000mg

Y

LEVODOPA/ CARBIDOPA MONOHYDRATE (Kinson® or Sinemet®)

Tablet

100/25mg & 250/25mg

Y

LEVODOPA/BENSERAZIDE (Madopar®)

Tablet

100/25mg

Y

LEVODOPA/BENSERAZIDE (Madopar®)

Capsule

100mg/25mg & 200mg/50mg

Y

LEVODOPA/BENSERAZIDE(Madopar® HBS)

Controlled Release Capsules

100/25mg

Y

LEVODOPA/CARBIDOPA MONOHYDRATE (Sinemet CR®)

Controlled Release Tablets

200/50mg

Y

LEVOFLOXACIN

Tablets

500mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

Blanket outpatient/inpatient approval for the treatment of Helicobacter pylori (H. pylori) infection following documented treatment failure with a clarithromycin based regimen; or, for primary treatment of H. pylori infection in a patient who cannot tolerate clarithromycin (due to drug allergy or unavoidable drug interactions).

LEVOMEPROMAZINE

Injection

25mg/mL

R

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

Blanket outpatient/inpatient approval for intractable nausea and vomiting and second line sedative for delirium/agitation in palliative care patients.

LEVONORGESTREL

Tablet

1.5mg

Y

LEVONORGESTREL (Mirena®)

Intra-uterine system (IUS)

52mg

R

Restricted to O&G use for:

Inpatients where access to Mirena® insertion in primary care is not appropriate or not available.

Outpatients where supply cannot be accessed via the PBS.

All Mirena® will be supplied by hospital pharmacies on an individual patient basis.

LEVOSIMENDAN

Injection

12.5mg

R

Restricted to ICU.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

LEVOTHYROXINE SODIUM (Brands: Eutroxsig and Oroxine only)

Tablet

50mcg & 100mcg

Y

LEVOTHYROXINE

Injection

200mcg/mL

R

Restricted to Endocrinologists, Emergency Medicine and Intensive Care Specialists for the treatment of myxoedema coma and symptomatic hypothyroidism in patients unable to be treated effectively with oral medications

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

LIDOCAINE/ ADRENALINE

Injection

1%/1:100,000, 2%/1:80,000, 2%/1:200,000

Y

LIDOCAINE

Ointment

5%

Y

LIDOCAINE

Injection

0.5%, 1% & 2% & 500mg

Y

LIDOCAINE

Topical Solution

4%

Y

LIDOCAINE

Jelly

2%

Y

LIDOCAINE

Catheter Syringe

2%

Y

LIDOCAINE

Spray

10%

Y

LIDOCAINE

Oral Gel

2%

Y

LIDOCAINE / GLUCOSE

Injection

0.4%/5%

Y

LIDOCAINE/PRILOCAINE (Emla®)

Patch

2.5%/2.5%

Y

LIGNOCAINE/PHENYEPHRINE (Co-phenylcaine Forte®)

Nasal Spray

5%/0.5%

Y

LINAGLIPTIN

Tablet

5mg

Y

LINEZOLID

Infusion

600mg/300mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

LINEZOLID

Tablet

600mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for treatment of infections approved by IFD.

LINEZOLID

Suspension

100mg/5mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

LIOTHYRONINE

Injection

20mcg

R

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

LIOTHYRONINE

Tablet

20mcg

Y

LIPASE/AMYLASE/PROTEASE (Creon®)

Micro granules

5000 units

Y

LIPASE/AMYLASE/PROTEASE (Creon®)

Capsule

10,000 & 25,000 units

Y

LIPID EMULSION (SMOFlipid®)

Emulsion

20%

Y

Blanket approval for Renal outpatients

LIQUID PARAFFIN EMULSION (Parachoc®)

Emulsion

Y

LIQUID PARAFFIN LIGHT (Hamilton®)

Bath Oil

500mL

Y

LIRAGLUTIDE (Saxenda®)

Syringe

6mg/mL

R

Blanket outpatient approval for RDPH Weight Management Clinic

LITHIUM CARBONATE

Tablet

250mg

Y

LITHIUM CARBONATE

Modified Release Tablets

450mg

Y

LOPERAMIDE (Gastro-Stop®)

Capsule

2mg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

LOPINAVIR & RITONAVIR

Tablet

200mg+50mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Or

Restricted to the ASCOT or REMAP CAP Trial as prescribed by the infectious disease and ICU consultants.

LOPINAVIR & RITONAVIR

Liquid

400mg+100mg/5mL (60mL)

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Or

Restricted to the ASCOT or REMAP CAP Trial as prescribed by the infectious disease and ICU consultants.

LORATADINE

Tablet

10mg

Y

LORAZEPAM

Tablet

1mg & 2.5mg

Y

LUBRICATING JELLY

Sachets or Tube

Y

MACITENTAN

Tablets

10mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

MACROGOL/POTASSIUM CHLORIDE/SODIUM BICARBONATE/SODIUM CHLORIDE LAXATIVE (Lax®)

Sachets

13.125g/46.6mg/178.5mg/350.7mg

Y

MAGNESIUM ASPARTATE TETRAHYDRATE

Tablet

500mg

Y

MAGNESIUM CHLORIDE

Injection

5mmol

Y

MAGNESIUM SULPHATE

Injection

2mmol & 10mmol

Y

MAGNESIUM SULPHATE CO (Magnoplasm®)

Paste

Y

MANNITOL

Injection

20%

Y

MEDIUM CHAIN TRIGLYCERIDE

Oil

Y

MEDIUM CHAIN TRIGLYCERIDES

Emulsion

Y

MEDROXYPROGESTERONE

Tablet

10mg & 100mg

Y

MEDROXYPROGESTERONE

Injection

150mg

Y

MEFLOQUINE

Tablet

250mg

Y

MELATONIN

Modified Release Tablet

2mg

Y

Restricted to Geriatrics, Rehabilitation and General medicine for inpatient use only for patients greater than 55 years of age with sleep disturbance, where other hypnotics are contraindicated (e.g. falls risk, dementia, behavioural disturbance), and non-pharmacological measures have been ineffective. For a maximum of 13 weeks.

MELPHALAN

Tablet

2mg

Y

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

MEMANTINE

Tablet

10mg

R

Restricted to patients who meet the PBS criteria

MENINGOCOCCAL ACWY VACCINE 4vMenCV

Injection

0.5mL

Y

For patients eligible under National Immunisation Program (NIP) Schedule only.

MENINGOCOCCAL C VACCINE (NeisVac-C®)

Injection

Y

MENINGOCOCCAL MULTICOMPONENT GROUP B VACCINE (Bexsero®)

Injection

0.5mL

Y

For patients eligible under National Immunisation Program (NIP) Schedule only.

MERCAPTOPURINE

Tablet

50mg

Y

MEROPENEM

Injection

500mg & 1g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

MESALAZINE

Enteric Coated Tablet

250mg

Y

MESNA

Injection

400mg & 1g

R

Restricted to Haematology and Oncology for PBS listed indications.

MESNA

Tablets

400mg & 600mg

R

Restricted to Haematology and Oncology for the prevention of haemorrhagic cystitis with cyclophosphamide or ifosfamide.

METARAMINOL

Injection

10mg/mL

Y

METARAMINOL

Pre-filled syringe

2.5mg/5mL & 5mg/10mL

Y

Stocked syringes:

RDH, GDH, KH: 2.5mg/5mL

ASH: 5mg/10mL

METFORMIN

Tablet

500mg, 850mg & 1000mg

Y

METFORMIN MR

Modified Release Tablet

500mg & 1000mg

Y

METHADONE

Tablet

10mg

Y

METHADONE

Injection

10mg

Y

METHADONE

Syrup

5mg/mL

R

Restricted to Addiction medicine prescribers, Pain team and Palliative Care.

METHOTREXATE

Tablet

2.5mg & 10mg

Y

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

METHOTREXATE

Syringe

10mg, 12mg, 15mg, 20mg, 25mg, 50mg & 75mg

Y

METHOTREXATE

Injection

5mg, 50mg, 500mg, 1gram & 5gram

R

Restricted to Haematology and Oncology for PBS listed indications.

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

Injection

30mcg, 50mcg, 75mcg, 100mcg, 120mcg, 200mcg & 360mcg.

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

METHOXYFLURANE

Liquid for inhalation

3mL

R

Restricted to haematology use for analgesia during bone marrow biopsy procedure

METHYL SALICYLATE/EUCALYPTUS MENTHOL

Rub

Y

METHYLDOPA SESQUIHYDRATE

Tablet

250mg

Y

METHYLENE BLUE

Injection

1% (50mg)

Y

METHYLNALTREXONE

Injection

12mg

R

Palliative Care and ICU only for treatment of opioid-induced constipation in patients who have failed to respond to laxatives.

METHYLPHENIDATE

Tablet

10mg

R

Use in attention deficit hyperactivity disorder

METHYLPREDISOLONE ACETATE (Depo- Nisolone®)

Depot injection

40mg/mL

Y

METHYLPREDISOLONE ACETATE in FATTY OINTMENT

Ointment

0.1%

Y

METHYLPREDNISOLONE SODIUM SUCCINATE

Injection

1g & 40mg

Y

METOCLOPRAMIDE

Injection

10mg

Y

METOCLOPRAMIDE

Tablet

10mg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

METOPROLOL

Modified Release Tablet

23.75mg, 47.5mg, 95mg & 190mg

Y

METOPROLOL

Tablet

50mg & 100mg

Y

METOPROLOL TARTRATE

Injection

1mg

Y

METRONIDAZOLE

Suspension

200mg/5mL

Y

METRONIDAZOLE

Suppositories

500mg

Y

METRONIDAZOLE

Tablet

200mg & 400mg

Y

METRONIDAZOLE

Infusion

500mg

Y

MICONAZOLE

Oral gel

2%

Y

MIDAZOLAM

Injection

5mg/mL, 5mg/5mL, 15mg/3mL & 50mg/10mL

Y

Blanket outpatient approval for epilepsy in paediatric patients (5mg/mL plastic ampoules).

Blanket outpatient approval for palliative care patients for various indications.

MIDODRINE

Tablet

2.5mg & 5mg

R

Blanket outpatient approval for management of symptomatic hypotension (including orthostatic and intradialytic) where non-pharmacological management has failed, restricted to medical and renal physicians.

MIFEPRISTONE

Tablet

200mg

Y

Restricted to Obstetrics & Gynaecology specialists for the medical termination of pregnancy beyond the first trimester up to 22 completed weeks gestation and beyond 22 weeks for foetal death in utero only.

MIFEPRISTONE/ MISOPROSTOL (MS 2 STEP®)

Tablet

200mg/200mcg

Y

Restricted to Katherine Hospital only, for medical termination of an intrauterine pregnancy (MTOP) up to 63 days gestation (PBS indications).

MS2Step can be accessed in community pharmacies in other areas of the NT.

MILRINONE

Injection

10mg/10mL

R

Restricted to ICU and CCU

MINOCYCLINE

Tablet

50mg

Y

MINOCYCLINE

Injection

100mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Prescribing to be restricted to Infectious disease (IFD) in susceptible infections for patients in whom other alternatives are inappropriate

MINOXIDIL

Tablet

10mg

Y

MIRTAZAPINE

Orally disintegrating tablet & tablets

15mg, 30mg & 45mg

Y

MISOPROSTOL

Tablet

200mcg

Y

MITOMYCIN

Eye drop

0.02%

R

Restricted to Ophthalmologist use only

MITOMYCIN

Bladder instillation Syringe

40mg

R

Restricted to Urologist

MITOMYCIN

Injection

R

0.02% & 0.05% for Ophthalmologist use.

Oncologist use for treatment of Anal Cancer.

MITOZANTRONE

Injection

20mg/10mL & 25mg/12.5mL

R

Restricted to Haematology and Oncology for PBS listed indications.

MIVACURIUM

Injection

20mg/10mL

Y

MMR VACCINE

Injection

Y

MOMETASONE FUROATE

Nasal Spray

50mcg

Y

MOMETASONE FUROATE

Lotion

1%

Y

MONKEYPOX (Jynneos®) VACCINE

R

Stock via National Medicines Stockpile (NMS).

MONKEYPOX VIRUS TREATMENTS

R

Restricted for use by Infectious Diseases and/or Sexual Health physicians.

Approved treatments are Tecovirimat 200mg capsules (Tpoxx®), Vaccinia Immunoglobulin (VIG) ≥50,000 units/15mL and Cidofovir 375mg/5mL injection vials (Empovir®).

Stock is managed via National Medicines Stockpile (NMS).  NMS approval required prior to access.

MORPHINE HCl MIXTURE

Mixture

1mg/mL & 5mg/mL

Y

MORPHINE INTRATHECAL

Injection

500microgram/mL

R

Restricted for use by anaesthetics for patients requiring spinal anaesthetic undergoing a caesarean section or as an adjunct analgesia for patients undergoing major surgery

MORPHINE SULFATE

Injection

10mg & 30mg

Y

Blanket outpatient approval for Palliative care patients.

MORPHINE SULFATE (Kapanol®)

Capsule

10mg, 20mg, 50mg & 100mg

Y

MORPHINE SULPHATE (MS Contin®) SLOW RELEASE

Slow Release Tablets

5mg, 10mg, 30mg, 60mg & 100mg

Y

MORPHINE TATRATE

Injection

120mg

R

Restricted to palliative care and pain team

Blanket outpatient approval for Palliative care patients.

MOXIFLOXACIN

Tablet & Injection

400mg & 400mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for treatment of infections approved by IFD (for oral form).

MOXONIDINE

Tablet

200mcg

Y

MULTI-B VITAMINS (Cenovis Mega-B®)

Tablet

Y

MULTIVITAMIN & MINERALS (Cenovis®)

Tablets

Y

MULTIVITAMIN (CERNEVIT)

Injection

Y

MULTIVITAMIN (Pentavite Infant®)

Infant drops

Y

MULTIVITAMIN WITH IRON (Pentavite®)

Syrup

Y

MULTIVITAMINS PLUS ZINC (VitABDECK®)

Capsule

R

Vitamin for Cystic Fibrosis patients.

Blanket outpatient approval as a vitamin for Cystic Fibrosis patients.

MUPIROCIN

Ointment & Nasal Ointment

2%

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

MYCOPHENOLATE MOFETIL

Capsule

250mg & 500mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Formulary for renal transplant use

MYCOPHENOLATE MOFETIL

Injection

500mg

Y

MYCOPHENOLATE SODIUM

(MYFORTIC®)

Tablet

180mg & 360mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Restricted for use in Lupus Nephritis HSD indications only. The capsules are the formulary mycophenolate option for renal transplant indications.

NALOXONE

Injection

400mcg

Y

NALOXONE

Nasal Spray

1.8mg

R

Restricted to Alcohol and Other Drug (AOD) prescribers for Opioid Pharmacotherapy (OPP) patients

NALTREXONE

Tablet

50mg

R

Restricted to Addiction Medicine prescribers for use as an adjunct for the treatment of alcohol dependence.

NAPHAZOLINE/ PHEIRAMINE (Naphcon-A®)

Eye drop

0.025%/0.3%

Y

NAPROXEN

Tablet

250mg

Y

NAPROXEN

Modified Release Tablet

1g

Y

NATALIZUMAB

Injection

300mg/15mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

NATAMYCIN

Eye drop

5%

Y

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

NEBIVOLOL

Tablet

1.25mg, 5mg

Y

Restricted to PBS criteria.

NEISSERIA MENINGITIDIS/HAEMOPHILUS INFLUENZAE TYPE B (HIB) (Menitorix®)

Injection

5microg/5microg

Y

NEOSTIGMINE

Injection

500mcg & 2.5mg

Y

NETUPITANT/PALONOSETRON

Capsules

300mcg/500mcg

R

Restricted to Haematology and Oncology for PBS listed indications.

NEVIRAPINE

Tablet

200mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

NEVIRAPINE

Modified Release Tablet

400mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

NICORANDIL

Tablet

10mg & 20mg

Y

NICOTINE

Inhaler

15mg

Y

NICOTINE

Patch

7mg, 14mg & 21mg

Y

NICOTINE

Gum

2mg & 4mg

Y

NICOTINE

Oral Strips

2.5mg

R

Restricted to Remote Health

NIFEDIPINE

Tablet

10mg & 20mg

Y

NIFEDIPINE MR

Modified Release Tablet

30mg & 60mg

Y

NIMODIPINE

Injection

10mg

Y

NIMODIPINE

Tablet

30mg

Y

NITAZOXANIDE

Suspension

100mg/5mL

Y

NITRIC OXIDE

Inhalation

800ppm

Y

NITROFURANTOIN

Capsule

50mg & 100mg

Y

NIVOLUMAB

Infusion

Variable

R

Restricted to Medical Oncologists for use in patients enrolled in the Nivolumab Extended Access Program.

NORADRENALINE

Injection

2mg

Y

NORETHISTERONE

Tablet

5mg

Y

NORFLOXACIN

Tablet

400mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

NYSTATIN

Capsules

500 000 units

Y

NYSTATIN

Oral drops

100 000 units

Y

OCTREOTIDE

Depot Injection

10mg, 20mg & 30mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

OCTREOTIDE

Injection

50mcg, 100mcg & 500mg

Y

OFLOXACIN

Eye drop

3mg

R

Restricted to Ophthalmologist use only

OLANZAPINE

Tablet

2.5mg, 5mg & 10mg

Y

OLANZAPINE

Injection

10mg

R

Restricted to Mental Health & ED

OLANZAPINE (Zyprexa Zydis®)

Wafers

5mg, 10mg. 15mg & 20mg

Y

OLANZAPINE PAMOATE (Zyprexa Relprevv®)

Long Acting Injection

210mg, 300mg & 405mg

R

Restricted to Mental Health

OLIVE OIL

Liquid

Y

OMEPRAZOLE

Solution

2mg/mL

Y

Manufactured at RDH.

Blanket outpatient approval for administration via NG/PEG tube in paediatric patients.

OMEPRAZOLE

Injection

40mg

Y

Pantoprazole is first line therapy

OMEPRAZOLE

Tablet

10mg & 20mg

Y

Pantoprazole is first line therapy

ONDANSETRON

Injection

4mg & 8mg

Y

ONDANSETRON

Wafers

4mg & 8mg

Y

OPSITE SPRAY DRESSING

Spray

Y

ORABASE (CARMELLOSE/ PECTIN/ GELATIN)

Paste

Y

ORAL REHYDRATION SALTS SOLUTION

Sachets

Ice Blocks

Y

OSELTAMIVIR

Liquid

6mg/mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

OSELTAMIVIR (Tamiflu®)

Capsule

30mg & 75mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

OXALIPLATIN

Injection

50mg, 100mg & 200mg

R

Restricted to Haematology and Oncology for PBS listed indications.

OXAZEPAM

Tablet

15mg & 30mg

Y

OXYBUPROCAINE

Minims

0.40%

Y

OXYBUTYNIN

Tablet

5mg

Y

OXYCODONE

Liquid

5mg/5mL

Y

OXYCODONE (Endone®)

Tablet

5mg

Y

OXYCODONE (Oxycontin SR ®)

Slow Release Tablets

10mg, 15mg 20mg, 30mg, 40mg & 80mg

Y

NB: Not all strengths are stocked at all sites

OXYCODONE (Oxynorm®)

Capsule

10mg & 20mg

Y

OXYCODONE HYDROCHLORIDE/NALOXONE HYDROCHLORIDE DIHYDRATE (Targin®)

Tablet

5/2.5mg, 10/5mg, 20/10mg & 40/20mg

R

Restricted to chronic pain when opioid-induced constipation is refractory to optimised regular laxatives

OXYCODONE

Intravenous

50mg/mL

R

Restricted to Acute Pain Service/Anaesthetics for Patient Controlled Analgesia (PCA)

OXYMETAZOLINE

Nasal Spray

0.05%

Y

OXYTOCIN

Injection

10units

Y

PACLITAXEL

Injection

30mg, 100mg, 150mg & 300mg

R

Restricted to Haematology and Oncology for PBS listed indications AND advanced or recurrent endometrial cancer, AND as neoadjuvant upper GI with RT.

PACLITAXEL NANOPARTICLE ALBUMIN BOUND

Injection

100mg

R

Restricted to Haematology and Oncology for PBS listed indications.

PALACOS R BONE CEMENT with GENTAMICIN

Cement

Y

PALIPERIDONE

Modified Release Tablet

3mg, 6mg & 9mg

R

Restricted to Mental Health

PALIPERIDONE PALMITATE 1 MONTHLY

Depot injection

25mg, 50mg, 75mg, 100mg & 150mg

R

Restricted to Mental Health

PALIPERIDONE PALMITATE 3 MONTHLY

Depot injection

175mg, 263mg, 350mg & 525mg

R

Restricted to Mental Health.

For initiation in the outpatient setting only in patients who meet PBS criteria.

PALONOSETRON

Injection

250mcg/5mL

R

Restricted to Haematology and Oncology for prevention of nausea and vomiting induced by moderately emetogenic chemotherapy protocols.

PAMIDRONATE DISODIUM

Injection

15mg & 90mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

PANCURONIUM

Injection

4mg

Y

PANITUMUMAB

Injection

100mg/5mL & 400mg/20mL

R

Restricted to Haematology and Oncology for PBS listed indications.

PANTHENOL/BENZALKONIUM CHLORIDE (BEPANTHEN®)

Cream

5%/0.05%

Y

PANTOPRAZOLE

Tablet

20mg & 40mg

Y

PANTOPRAZOLE

Injection

40mg

Y

PAPAVERINE

Injection

120mg

Y

PARACETAMOL

Tablet

500mg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

PARACETAMOL

Suppositories

125mg, 250mg & 500mg

Y

PARACETAMOL

Drops & Elixir

100mg/mL & 240mg/5mL

Y

PARACETAMOL

Soluble Tablet

500mg

Y

PARACETAMOL

Injection

1000mg

R

Restricted for post-surgery and patients unable to tolerate oral or rectal route

PARACETAMOL & CODEINE

Tablet

500mg/30mg

Y

PARACETAMOL MR

Modified Release Tablet

665mg

R

Restricted to Palliative Care & Remote Health

PARAFFIN CO

Eye ointment

3.5g

Y

PARAFFIN EMULSION (Parachoc®)

Oral Liquid

2.5mL/5mL

Y

PARAFFIN STERILE

Sterile Liquid

5g

Y

PARAFFIN WHITE SOFT

Cream

10g (sterile), 50g & 500g

Y

PARAFFIN WHITE SOFT & LIQUID PARAFFIN

Ointment

50%/50%

Y

PARALDEHYDE

Injection

Y

NB: Not stocked at all sites. May need to be ordered on a case by case basis.

PARECOXIB SODIUM

Injection

40mg

R

Restricted to Pain team and ICU

PATENT BLUE VIOLET 2.5%

Pre-Filled Syringe

2.50%

Y

PATIROMER

Sachets

8.4g

R

Restricted to renal team/nephrologists for short-term use in patients with End Stage Renal Disease on haemodialysis where renal replacement therapy is not accessible.

PAW-PAW OINTMENT

Ointment

Y

PAZOPANIB

Tablet

200mg & 400mg

R

Restricted to Haematology and Oncology for PBS listed indications.

PEGFILGRASTIM

Injection

6mg/0.6mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

PEMETREXED

Injection

100mg & 500mg

R

Restricted to Haematology and Oncology for PBS listed indications.

PENTAMIDINE

Injection

300mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Restricted to haematology/oncology patients and others under the management /recommendation of IFD

PEPPERMINT

Lip Balm

20g

R

Restricted to Palliative Care only

PERHEXILINE

Tablet

100mg

Y

PERINDOPRIL

Tablet

2.5mg, 5mg & 10mg

Y

PERINDOPRIL ARGININE & INDAPAMIDE

Tablet

5mg/1.25mg

Y

PERMETHRIN

Cream

5%

Y

PHENTERMINE

Tablet

15mg

R

Blanket outpatient approval for RDPH Weight Management Clinic

PHENTOLAMINE MESYLATE

Injection

5mg

R

Restricted to Emergency Department for the treatment of dermal necrosis and sloughing following intravenous administration or extravasation of noradrenaline or adrenaline.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

PHENOBARBITAL

Injection

200mg

Y

PHENOBARBITAL

Tablet

30mg

Y

PHENOBARBITAL

Syrup

15mg/5mL

Y

PHENOXYMETHYLPENICILLIN

Capsule

250mg & 500mg

Y

PHENOXYMETHYLPENICILLIN (PENICILLIN V)

Suspension

150mg/5mL

Y

PHENYLEPHRINE

Minims

2.5% & 10%

Y

PHENYTOIN

Injection

100mg & 250mg

Y

PHENYTOIN

Chewable tablets

50mg

Y

PHENYTOIN

Capsule

30mg & 100mg

Y

PHENYTOIN

Suspension

30mg/5mL

Y

PHOSPHATE (Fleet®)

Enema

133mL

Y

PHOSPHATE, SODIUM ACID (Phosphate Sandoz®)

Effervescent Tablet

500mg

Y

PHYSOSTIGMINE

Injection

2mg

Y

PHYTOMENADIONE (Vitamin K®)

Injection

2mg & 10mg

Y

Blanket outpatient approval.

PILOCARPINE

Minims

2%

R

Restricted to eye department

PILOCARPINE (with preservative)

Eye drop

1%, 2% & 4%

Y

PIMECROLIMUS

Cream

1%

R

For patients who fail to hydrocortisone 1% cream/ointment.

PIPERACILLIN & TAZOBACTAM

Infusor

Variable

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

PIPERACILLIN & TAZOBACTAM

Injection

4g/0.5g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

PIROXICAM

Capsule

10mg

Y

PLASMA-LYTE 148 in WATER

IV fluid

Y

PLASMA-LYTE 148 with GLUCOSE 5%

IV fluid

1 L

R

For paediatric use

PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (Paediatric)

Injection

Y

PNEUMOCOCCAL VACCINE 23 VALENT (Adult)

Injection

Y

PODOPHYLLOTOXIN

Solution

0.50%

Y

PODOPHYLLOTOXIN

Cream

0.15%

Y

POLIOMYELITIS VACCINE (Ipol®)

Injection

Y

POLOXAMER

Drops

100mg/mL

Y

POLYMYXIN B

Injection

500,000 units

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Prescribing to be restricted to Infectious disease (IFD) in susceptible infections for patients in whom other alternatives are inappropriate

POLYVINYL ALCOHOL

Eye drops

1.40%

Y

PORACTANT

Suspension for intratracheal administration

240mg/3mL

Y

POSACONAZOLE

Modified Release Tablet & Oral Suspension

100mg & 40mg/mL (105mL)

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for non-PBS indications, restricted to Haematology and Oncology/ Infectious Diseases.

POSACONAZOLE

Injection

300mg/16.7mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

POTASSIUM ACETATE

Injection

25mmol

Y

POTASSIUM CHLORIDE

Effervescent tablets

14mmol

Y

POTASSIUM CHLORIDE

Injection

10mmol/10mL

Y

POTASSIUM CHLORIDE

Modified Release Tablet

600mg

Y

POTASSIUM CHLORIDE FOR DIALYSIS

Solution

26.1%w/v

Y

POTASSIUM CHLORIDE in GLUCOSE

IV fluid

10mmol/10% in 500mL

Y

POTASSIUM CHLORIDE in SODIUM CHLORIDE

IV fluid

10mmol/0.29% in 100mL, 20mmol/0.9% in 1000mL, 30mmol/0.9% in 1000mL, 40mmol/0.9% in 1000mL

Y

POTASSIUM CHLORIDE in SODIUM LACTATE COMPOUND

IV fluid

30mmol in 1L

Y

POTASSIUM CHLORIDE in SODIUM CHLORIDE with GLUCOSE

IV fluid

20mmol/0.18%/4% in 1L,

20mmol/0.9%/5% in 1L,

40mmol/0.9%/5% in 1L,

10mmol/0.225%/

10% in 500mL

Y

POTASSIUM DIHYDROGEN PHOSPHATE

Injection

10mmol/10mL

R

Wards can contact pharmacy or ICU liaison if further support is required

POTASSIUM PERMANGANATE

Crystals

Y

POVIDONE IODINE

Solution

7.50%

Y

POVIDONE IODINE

Scrub Brush

Y

POVIDONE IODINE

Ointment Sachets

10%

Y

POVIDONE IODINE (100mL)

Solution

10%

Y

POVIDONE IODINE ALCOHOLIC

Skin Preparation

Y

PRALIDOXIME IODIDE

Injection

500mg

Y

PRAMIPEXOLE

Tablet

180mcg & 250mcg

R

Restricted to remote patients with Machado Joseph Disease

PRAZIQUANTEL

Tablet

600mg

Y

Blanket approval for outpatient supply. Restricted to the treatment of Hymenolepsis nana (dwarf tape worm) infection.

PRAZOSIN

Tablet

1mg, 2mg & 5mg

Y

PREDNISOLONE

Tablet

1mg, 5mg & 25mg

Y

Blanket approval for outpatient supply. Restricted to: Haematology/Oncology.

PREDNISOLONE

Suspension

25mg/5mL

Y

PREDNISOLONE & PHENYLEPHRINE (PREDNEFRIN FORTE EYE®)

Eye drops

1%/0.12%

Y

PREDNISOLONE ENEMA

Enema

0.2mg/mL

Y

PREDNISOLONE SODIUM PHOSPHATE

Eye drop minims

0.5%

R

Restricted to use by ophthalmology.

Blanket outpatient approval for patients with allergy to preservatives in prednisolone containing eye drops or for patients where prednisolone as a single ingredient is required.

PREGABALIN

Capsule

25mg, 75mg & 150mg

R

Blanket outpatient approval for neuropathic pain for patients with fibromyalgia syndrome only. Prescriber to annotate script as “fibromyalgia syndrome/non-PBS indication”.

PREGNANCY TEST

Strip

Y

PRILOCAINE

Injection

0.50%

Y

PRIMAQUINE

Tablet

7.5mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for prevention or relapse of malaria or treatment of Pneumocystis carinii pneumonia (PCP).

PRIMIDONE

Tablet

250mg

Y

PROBENECID

Tablet

500mg

Y

PROCARBAZINE

Capsule

50mg

R

Restricted to Haematology and Oncology for BEACOPP (Hodgkin Lymphoma) AND PCV (Neuro).

PROCHLORPERAZINE

Injection

12.5mg/5mL

Y

PROCHLORPERAZINE

Tablet

5mg

Y

PROGESTERONE

Pessaries

200mg

R

Restricted to O&G for PBS listed indications.

PROMETHAZINE

Elixir

1mg/mL

Y

PROMETHAZINE

Tablet

10mg & 25mg

Y

PROMETHAZINE

Injection

50mg

R

Restricted to haematology/oncology patients on chemotherapy requiring hypersensitivity reaction rescue AND remote primary health care for indications outlined in CARPA

PROPANTHELINE

Tablet

15mg

Y

PROPOFOL

Injection

200mg & 500mg

Y

PROPRANOLOL

Suspension

10mg/5mL

Y

PROPRANOLOL

Tablet

10mg, 40mg & 160mg

Y

PROPYLENE GLYCOL

Solution

Y

PROPYLTHIOURACIL

Tablet

50mg

Y

PROTAMINE SULPHATE

Injection

50mg/5mL

Y

PSEUDOEPHEDRINE

Tablet

60mg

Y

PSYLLIUM

Powder

Y

PYRANTEL

Tablet

125mg

Y

PYRAZINAMIDE

Tablet

500mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of tuberculosis by TB clinic/IFD.

PYRIDOSTIGMINE

Tablet

10mg & 60mg

Y

PYRIDOXINE

Tablet

25mg

Y

Blanket outpatient approval for the prevention of isoniazid-induced peripheral neuropathy.

PYRIMETHAMINE

Tablet

25mg

Y

QUETIAPINE

Tablet

25mg, 100mg, 200mg & 300mg

Y

QUETIAPINE

Modified Release Tablet

50mg, 200mg & 300mg

Y

RABIES VACCINE

Injection

Y

RALTEGRAVIR

Tablet

400mg

600mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

RALTITREXED

Injection

2mg

R

Restricted to Haematology and Oncology for PBS listed indications.

RAMIPRIL

Tablet & capsules

1.25mg, 2.5mg, 5mg & 10mg

Y

RANIBIZUMAB

Injection

2.3mg & 3mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

RASBURICASE

Injection

1.5mg/1mL

R

Restricted to use in Haematology and Oncology for the treatment of acute hyperuricaemia of presumed or confirmed tumour lysis syndrome, in accordance with approved guidelines.

REMDESIVIR

Injection

100mg

R

Restricted to prescribing by ICU and IFD Physicians for COVID – 19 Patients on ICU and 4B who are 12 years or older and weigh at least 40kg with pneumonia and requiring supplemental oxygenation.

REMIFENTANIL

Injection

1mg & 5mg

Y

RETEPLASE

Injection

10 units

Y

Short-term listing for thrombolysis in acute STEMI while tenecteplase is out of stock.

RIBAVIRIN (Ibavyr®)

Tablet

200mg

S

Restricted to specialists working in the liver clinic running the HCV treatment program. For initiation in outpatients via the Highly specialised Drugs Program (Section 100). Refer to PBS Criteria.

RIFABUTIN

Capsule

150mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

RIFAMPICIN

Syrup

100mg/5mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for susceptible infections not listed on the PBS approved by Infectious Diseases.

RIFAMPICIN

Injection

600mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

RIFAMPICIN

Capsule

150mg & 300mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for susceptible infections not listed on the PBS approved by Infectious Diseases.

RIFAPENTINE

Tablet

150mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for the treatment of latent tuberculosis by TB clinic/IFD.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

RIFAXIMIN

Tablet

550mg

Y

Restricted to PBS indications.

RILPIVIRINE

Tablet

25mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

RISPERIDONE

Solution

5mg/5mL

Y

RISPERIDONE

Tablet

0.5mg, 1mg 2mg, 3mg & 4mg

Y

RISPERIDONE (CONSTA®)

Depot Injection

25mg, 37.5mg & 50mg

R

Restricted to Mental Health for continuing treatment in patients already stabilised on Risperidone depot, or initial treatment in patients where paliperidone depot is unsuitable or not tolerated.

RITONAVIR

Tablet

100mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

RITUXIMAB

Injection

100mg/10mL, 500mg/50mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

RITUXIMAB

Infusion

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

RIVAROXABAN

Tablets

10mg,15mg & 20mg

R

Restricted to PBS indications.

RIZATRIPTAN

Wafer

10mg

Y

Short-term listing while oral zolmitriptan is out of stock.

ROCURONIUM

Injection

50mg

Y

ROPIVACAINE

Injection

75mg/10mL

Y

Other strengths are available on request.

ROSUVASTATIN

Tablets

5mg, 10mg, 20mg & 40mg

Y

ROTAVIRUS ORAL VACCINE

Oral Solution

Y

ROXITHROMYCIN

Tablet

150mg

Y

SACUBITRIL WITH VALSARTAN

Tablet

24mg/26mg, 49mg/51mg, 97mg/103mg

Y

Restricted to PBS indications.

SALBUTAMOL

Injection

500mcg

Y

SALBUTAMOL

Nebuliser

2.5mg & 5mg

Y

SALBUTAMOL

Inhaler

100mcg

Y

SALICYLIC ACID / COAL TAR in AQUEOUS CREAM

Cream

6%/6%

Y

SALICYLIC ACID/ LACTIC ACID

Paint

16.70%

Y

SALINE LAXATIVE (Fleet®) FLEET

Mixture & Enema

Y

SALIVA ARTIFICIAL

Solution

Y

SEMAGLUTIDE

Syringe

1.34mg/mL (1.5mL & 3mL)

R

Restricted to PBS indications.

(Use restricted to continuation treatment only; Treatment initiation requires IPU approval)

SENNA

Tablets

7.5mg

Y

SERTRALINE

Tablets

50mg & 100mg

Y

SEVELAMER

Tablets

800mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

SEVOFLURANE

Liquid for inhalation

Y

SILDENAFIL

Injection

10mg/12.5ml

R

Restricted to ICU use only for patients with pulmonary arterial hypertension.

SILDENAFIL

Tablets

20mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

SILVER NITRATE/POTASSIUM NITRATE

Pencil & Sticks

427.5mg/22.5mg

Y

SILVER SULPHADIAZINE

Cream

1%

Y

SIMETHICONE

Drops

100mg/mL

Y

SIMETHICONE

Liquid

120mg/mL

Y

*For short-term listing while drops are out of stock

SIMVASTATIN

Tablet

10mg, 20mg 40mg & 80mg

Y

SIROLIMUS

Tablet

0.5mg, 1mg & 2mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

SITAGLIPTIN

Tablet

25mg, 50mg & 100mg

Y

SOAP ENEMA

Enema

5%

Y

SODA LIME (Medisorb®)

Prepacked Canister

Y

SODIUM BENZOATE

Injection

2g/10mL

R

Restricted to Paediatricians under the advice of a Metabolic Specialist for the emergency treatment of hyperammonaemia in urea cycle defects.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

SODIUM BICARBONATE

Capsule

840mg

Y

SODIUM BICARBONATE

Injection & Mini-jet

100mmol

Y

Mini-jet is restricted to resuscitation room in the emergency department

SODIUM CHLORIDE

Tablets

600mg

Y

SODIUM CHLORIDE

Injection

0.9%/5% (1L)

Y

SODIUM CHLORIDE

Eye Drops

5%

R

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

Blanket outpatient approval for corneal oedema.

SODIUM CHLORIDE

Injection

0.45% (500mL), 0.9% (10mL, 20mL, 50mL, 100mL, 250mL, 500mL, 1L & 2L), 3% (1L), 23.4% (10mL),

Y

SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE, GLUCOSE ANHYDROUS, CALCIUM LACTATE PENTAHYDRATE (Flo®)

Nasal Sachets/ Irrigation kit

R

Restricted to ENT and Radiation Oncology

SODIUM CHONDROITIN SULPHATE/SODIUM HYALURONATE (Viscoat®)

Eye Irrigation

40mg/30mg/mL

Y

SODIUM CITRATE

Solution

8.80%

Y

SODIUM CITRATE/ SODIUM LAURYL SULFOACETATE (Microlax®)

Enema

90mg/9mg/mL

Y

SODIUM CITRO-TARTRATE

Sachets

Y

SODIUM CROMOGLYCATE

Eye Drops

2%

Y

SODIUM DIHYDROGEN PHOSPHATE

Injection

10mmol/10mL

Y

FUSIDIC ACID HEMIHYDRATE

Tablet

250mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for susceptible infections not listed on the PBS approved by Infectious Diseases.

SODIUM HYALURONATE (Provisc®)

Intraocular Injection

8.5mg/0.85mL

Y

SODIUM LACTATE CO (Hartmann’s®)

IV fluid

Y

SODIUM NITROPRUSSIDE

Injection

50mg

Y

SODIUM PICOSULFATE

Oral liquid

7.5mg/mL

R

Restricted to palliative care.

SODIUM PICOSULFATE, MAGNESIUM OXIDE & CITRIC ACID (Picoprep®)

Sachets

Y

SODIUM POLYSTYRENE SULFONATE (Resonium A®)

Powder

454g

Y

SODIUM SULFATE DECAHYDRATE / MACROGOL/ ELECTROLYTES (COLONLYTELY®)

Sachets

Y

SODIUM TETRADECYL SULPHATE

Injection

3%

Y

SODIUM THIOSULFATE

Injection

25g/100mL

R

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

Blanket outpatient approval for calciphylaxis, restricted to nephology.

SODIUM VALPROATE

Injection

400mg

Y

SODIUM VALPROATE

Suspension

200mg/5mL

Y

SODIUM VALPROATE

Chewable tablets

100mg

Y

SODIUM VALPROATE

Enteric Coated Tablet

200mg & 500mg

Y

SOFOSBUVIR/VELPATASVIR (Epclusa®)

Tablet

400mg/100mg

S

Restricted to specialists working in the liver clinic running the HCV treatment program. For initiation in outpatients via the Highly specialised Drugs Program (Section 100). Refer to PBS Criteria.

SOFOSBUVIR/VELPATASVIR/ VOXILAPREVIR (VOSEVI®)

Tablet

400mg/100mg/ 100mg

S

Restricted to specialists working in the liver clinic running the HCV treatment program. For initiation in outpatients via the Highly specialised Drugs Program (Section 100). Refer to PBS Criteria.

SOMATROPIN

Injection

1mg, 8mg, 10mg & 12mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

SORAFENIB

Tablet

200mg

R

Restricted to Haematology and Oncology for PBS listed indications.

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

SORBITOL

Solution

70%

Y

SOTALOL

Injection

40mg

Y

SOTALOL

Tablet

80mg & 160mg

Y

SPACER – DISPOSABLE

R

For use by Emergency Department and NCCRTC only.

SPACER FOR AEROSOL

Y

SPILL KIT FOR CYTOTOXIC DRUGS

Y

SPIRONOLACTONE

Tablet

25mg & 100mg

Y

SPIRONOLACTONE

Solution

12.5mg/5mL

Y

STREPTOMYCIN

Injection

1g

Y

SUCROFERRIC OXYHYDROXIDE

Chewable tablet

2.5 g

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

SUCROSE

Oral Solution

24%

Y

SUFENTANIL

Injection

50mcg

R

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

Blanket outpatient approval for cancer pain.

SUGAMMADEX

Injection

200mg

R

Restricted to use by Anaesthetic, ICU and ED specialists only.

SULFASALAZINE

Enteric Coated Tablet

500mg

Y

SULPHAMETHOXAZOLE/ TRIMETHOPRIM (Bactrim®)

Suspension

200mg/40mg/ 5mL

Y

SULPHAMETHOXAZOLE/ TRIMETHOPRIM (Bactrim®)

Tablet

400mg/80mg & 800mg/160mg

Y

Blanket outpatient approval for melioidosis eradication and Pneumocystis carinii pneumonia (PCP). Restricted to: Haematology/Oncology and Infectious Diseases.

SULPHAMETHOXAZOLE/ TRIMETHOPRIM (Bactrim®)

Injection

400mg/80mg

Y

SUNITINIB

Capsule

12.5mg, 25mg & 50mg

R

Restricted to Haematology and Oncology for PBS listed indications.

SUNSCREEN SPF

Lotion

15+, 30+

Y

SUNSCREEN with ZINC

CREAM

50+

Y

SUXAMETHONIUM

Injection

100mg

Y

TACROLIMUS

Capsule

500mcg, 1mg & 5mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

TACROLIMUS XL

Extended Release Capsule

500mcg, 1mg, 3mg & 5mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

TALC (STERILE LARGE PARTICLE) (Steritalc®)

Powder

4g

Y

TAMOXIFEN

Tablet

10mg & 20mg

Y

TAMSULOSIN

Tablets

400mcg

R

Restricted to urologists and geriatricians.

Restricted ONLY for the treatment of benign prostate hypertension (BPH) in patients where prazosin is not appropriate or not tolerated.

TAPENTADOL IR

Immediate Release Tablet

50mg

R

Restricted to;

Continuing inpatient use (regular medicine) OR

Initiation of treatment by Acute Pain Service, Geriatricians or Rehabilitation Consultants that meet the following;

Inpatient use only AND

Patients with severe incident-pain and complex pain management needs where its use will form part of a multimodal analgesic regimen AND

Patient has contraindications to the use of tramadol (indicate reason)

Taking other medication with serotonergic effects

At risk of seizures (Note: Tapentadol should be prescribed with care in patient at risk of seizures)

Other (reasons to be provided)

AND

Plan for analgesia requirements on discharge has been considered and documented if required. Tapentadol immediate release tablets cannot be supplied on discharge from hospital

TAPENTADOL SR

Slow Release Tablet

50mg, 100mg, 150mg, 200mg & 250mg

R

Restricted to PBS indications.

TEA TREE

Oil

Y

TEICOPLANIN

Injection

400mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

TEMAZEPAM

Tablet

10mg

Y

TEMOZOLOMIDE

Capsule

5mg, 20mg, 100mg, 140mg, 180mg & 250mg

R

Restricted to Haematology and Oncology for PBS listed indications.

TENECTEPLASE

Injection

50mg

Y

Restricted for acute myocardial infarction in the settings of pre-hospital thrombolysis (e.g. ambulance service, Careflight, RFDS), small rural hospitals (GDH, KDH, Tennant Creek Hospital), Alice Springs Hospital and remote facilities (Aboriginal health services).

TENOFOVIR DISOPROXIL

Tablet

300mg OR 291mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Blanket outpatient approval for management of Hepatitis B in pregnancy.

TENOFOVIR DISOPROXIL & EMTRICITABINE

Tablet

300mg+200mg

OR 291mg+200mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

TENOFOVIR DISOPROXIL,  EMTRICITABINE & EFAVIRENZ

Tablet

300mg+200mg+ 600mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

TERBINAFINE

Tablet

250mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

TERBINAFINE

Cream

1%

R

Restricted to indications meeting PBS criteria.

TERBUTALINE

Injection

500mcg/mL

R

Restricted to use in obstetrics for pregnant women with foetal distress requiring immediate delivery, or prior to External Cephalic Version (ECV)

TERBUTALINE

Turbuhaler

500mcg

Y

TERLIPRESSIN

Injection

0.85mg/mL

R

Restricted to Emergency Physicians, Intensive Care Physicians and Gastroenterologists for haemorrhaging oesophageal varices.

Restricted to Intensive Care Physicians, Gastroenterologists and Nephrologists for Type 1 Hepatorenal Syndrome.

TESTOSTERONE ESTERS

Injection

100mg & 250mg

Y

TETRABENAZINE

Tablet

25mg

Y

TETRACAINE (AMETHOCAINE) HYDROCHLORIDE

Minims

1%

Y

TETRACAINE (AMETHOCAINE) HYDROCHLORIDE

Gel

4%

Y

TETRACAINE (AMETHOCAINE) HYDROCHLORIDE / LIDOCAINE/ ADRENALINE (EPINEPHRINE) (LACERAINE®)

Gel

40mg/5mg/1mg/5mL

Y

TETRACAINE (AMETHOCAINE) / LIDOCAINE/ ADRENALINE (EPINEPHRINE)

Injection

0.5%/ 4%/ 1:1000

Y

TETRACOSACTIDE (TETRACOSACTRIN) (Synacthen®)

Injection

250mcg & 1mg

Y

THALIDOMIDE

Capsule

50mg, 100mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

THEOPHYLLINE

Modified Release Tablet

200mg, 250mg & 300mg

Y

THIAMINE

Tablet

100mg

Y

THIAMINE

Injection

300mg

Y

THIOPENTONE

Injection

500mg

Y

THROMBIN

Injection

5000units

Y

THYMOL

Mouthwash

Y

TICAGRELOR

Tablet

90mg

R

Restricted to Cardiologists & Interventional Cardiologists for patients undergoing planned PCI and CABG, and for patients who have had a cardiac event whilst taking clopidogrel.

TIGECYCLINE

Injection

50mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

TIMOLOL

Eye Drops

0.25% & 0.5%

Y

TIMOLOL LA

Long Acting Eye drops

0.50%

Y

TIOGUANINE

Tablet

40mg

R

Restricted to Haematology and Oncology for PBS listed indications.

Blanket approval for outpatient supply with PBS prescription. Restricted to: Haematology/Oncology.

TIOTROPIUM

Capsules for Inhalation

18mcg

Y

TIOTROPIUM

Inhaler

Y

TIROFIBAN

Injection

12.5mg

R

Restricted to Cardiology

TOBRAMYCIN

Injection

80mg (with preservative & preservative free for inhalation) & 500mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

TOBRAMYCIN

Eye drops

0.3% & 1.4% (1.4% compounded)

R

Restricted to Ophthalmologist use only.

Blanket outpatient approval for treatment or prevention of ophthalmic infections.

TOBRAMYCIN

Eye ointment

0.30%

Y

TOCILIZUMAB

Injection

200mg & 400mg

Restricted to ICU Physicians as per use in REMAP CAP clinical trials only

TOPIRAMATE

Sprinkle Capsule

25mg

Y

TOPIRAMATE

Tablet

25mg, 50mg & 100mg

Y

Blanket outpatient approval for RDPH Weight Management Clinic

TOPOTECAN

Injection

4mg

R

Restricted to Haematology and Oncology for PBS listed indications AND Small Cell Lung Cancer, AND Neuroendocrine Unknown Primary Cancer.

TPN ADULT STD TRIPLE PHASE BAG (SmofKabiven®)

IV fluid

1970mL

Y

TPN NEONATE 34 WEEK TO TERM

IV fluid

1200mL

Y

Order on request

TPN NEONATE CONCENTRATED PRETERM

IV fluid

750mL

Y

Order on request

TPN NEONATE HIGH SODIUM PRETERM

IV fluid

750mL

Y

Order on request

TPN NEONATE PRETERM (7.5% GLUCOSE)

IV fluid

750mL

Y

Order on request

TPN NEONATE STANDARD PRETERM

IV fluid

750mL

Y

RDH Stocked

TPN NEONATE STARTER

IV fluid

750mL

Y

RDH Stocked

TRAMADOL

Capsule

50mg

Y

TRAMADOL

Injection

100mg

Y

TRANEXAMIC ACID

Injection

1000mg/10mL

Y

TRANEXAMIC ACID

Tablet

500mg

Y

TRASTUZUMAB

Injection

60mg, 150mg, 600mg/5mL

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

TRIAMCINOLONE

Injection

10mg & 40mg

Y

TRIAMCINOLONE

Dental paste

0.10%

Y

TRICLOSAN

Solution

1%

Y

TRIHEXYPHENIDYL (BENZHEXOL) HYDROCHLORIDE

Tablet

2mg

Y

TRIMETHOPRIM

Tablet

300mg

Y

TROPICAMIDE

Minims

0.5% & 1%

Y

TROPONIN

Test strips

Y

TRYPAN BLUE

Injection

0.10%

Y

TUBERCULIN PPD

Injection

100units/mL

Y

ULIPRISTAL ACETATE

Tablet

30mg

R

Restricted to women who require emergency contraception between 72 to 120 hours after unprotected intercourse or contraception failure (For GDH only).

UMECLIDINIUM (Ellipta Incruse®)

Inhaler

62.5mcg

Y

UMECLIDINIUM / FLUTICASONE/ VILANTEROL (Ellipta Trelegy®)

Inhaler

62.5mcg/ 100mcg/ 25mcg

Y

UMECLIDINIUM / VILANTEROL (Ellipta Anoro®)

Inhaler

62.5mcg/ 25mcg

Y

UREA & LACTIC ACID (Calmurid®)

Cream

10%/5%

Y

UREA (Dermadrate®)

Cream

10%

Y

UREA (Ure-Na®)

Sachets

15gm

R

Restricted to Endocrinology.

This is a Special Access Scheme (SAS) product. Please complete appropriate SAS form which can be located on the TGA website.

URINE STRIPS

Strips

UROKINASE

Vial

5,000 units

10,000 units

25,000 units

100,000 units

Y

Short-term listing for fibrinolytic management of obstructed Central Vascular Access Devices (CVADs).

*Strengths subject to availability

URSODEOXYCHOLIC ACID

Suspension

250mg/5mL

Y

URSODEOXYCHOLIC ACID

Capsule

250mg

Y

Blanket outpatient approval for obstetric cholestasis.

USTEKINUMAB

Injection

130mg and 45mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

Note: The 45mg injection is to be sourced under PBS general schedule for outpatients.

VALACICLOVIR

Tablet

500mg

S

Restricted to PBS criteria

Blanket inpatient/outpatient approval for viral prophylaxis in haematology patients undergoing suppressive chemotherapy OR Ophthalmic Herpes Simplex.

VALGANCICLOVIR

Tablet

Oral Liquid

450mg

50mg/mL

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket inpatient/outpatient approval for treatments and prophylaxis of susceptible infections not listed on the PBS approved by Infectious Diseases.

VANCOMYCIN

Infusor

Variable

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

VANCOMYCIN

Injection

500mg & 1g

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

VARICELLA ZOSTER (Chicken Pox®) VACCINE

Injection

Y

VECURONIUM

Injection

4mg, 10mg

Y

VEDOLIZUMAB

Injection

300mg

S

Restricted to Gastroenterologists for Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

VENLAFAXINE

Modified Release Capsule

37.5mg, 75mg & 150mg

Y

VERAPAMIL

Injection

5mg

Y

VERAPAMIL

Tablet

40mg & 80mg

Y

VERAPAMIL

Modified Release Capsule

180mg & 240mg

Y

VINBLASTINE

Injection

10mg/10mL

R

Restricted to Haematology and Oncology for PBS listed indications.

VINCRISTINE

Injection

1mg/mL

R

Restricted to Haematology and Oncology for PBS listed indications.

VINORELBINE

Capsule

20mg & 30mg

R

Restricted to Haematology and Oncology for PBS listed indications.

VINORELBINE

Injection

10mg/mL, 50mg/5mL

R

Restricted to Haematology and Oncology for PBS listed indications.

VITAMIN A

Ointment

Y

VITAMIN A (RETINOL PALMITATE)

Capsule

50,000units

Y

VITAMIN B COMPLEX (Cenovis Mega B®)

Tablets

Y

VITAMIN E

Oral Liquid

156iu

Y

VITAMIN PREGNANCY & BREASTFEEDING (I-Folic®)

Tablets

R

Restricted to remote health and maternity inpatients for women who are pregnant or breastfeeding.

VORICONAZOLE

Injection

200mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

VORICONAZOLE

Tablet

50mg & 200mg

R

Restricted antimicrobial - Please refer to the Restricted Antimicrobial Guideline NT

Blanket outpatient approval for susceptible infections not listed on the PBS approved by Infectious Diseases.

WARFARIN

(Coumadin® Brand)

Tablet

1mg, 2mg & 5mg

Y

WATER FOR INJECTIONS

Injection

10mL, 20mL & 1L

Y

WATER FOR IRRIGATION

Irrigation

1L & 2L

Y

WOOL ALCOHOLS

Ointment

100g

Y

XYLOMETAZOLINE

Nasal Drops

0.05%

Y

ZINC & CASTOR OIL

Cream

20g

Y

ZINC (Elemental)

Capsule

50mg

Y

ZINC OXIDE

Cream

Y

ZINC SULPHATE

Solution

50mg/mL

Y

Contains elemental Zinc 11.3mg/mL.

ZOLEDRONIC ACID

Injection

5mg

Y

Blanket outpatient approval for osteoporosis in patients who don’t meet PBS criteria.

ZOLEDRONIC ACID

Injection

4mg

S

Highly Specialised Drugs Program (Section 100). Refer to PBS Criteria.

ZOLMITRIPTAN

Tablet

2.5

Y

ZOSTER VACCINE (Shingrix®)

Injection

0.5mL

Y

For patients eligible under National Immunisation Program (NIP) Schedule only.

ZUCLOPENTHIXOL ACETATE

Injection

50mg

R

Restricted to prescribing by or upon consultation with psychiatrists.

ZUCLOPENTHIXOL

Tablet

10mg

Y

ZUCLOPENTHIXOL DECANOATE

Injection

200mg

Y